Research Reports in

Diabetic Neuropathy – Drug Pipeline Landscape, 2022
November, 2022

Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes. High blood sugar levels can damage the nerves over time. This type of damage is called neuropathy. Diabetic neuropathy can affect different parts of the body, including the feet, legs, hands, and arms. It can also affect the digestive system, urinary system, blood vessels, and heart. Diabetic neuropathy is a serious complication of diabetes. It can lead to problems with the feet, legs, and hands. It can also lead to problems with the digestive system, urinary system, blood vessels, and heart.

Diabetic neuropathy can cause due to the high blood glucose levels, also called blood sugar, and high levels of fats, such as triglycerides, in the blood from diabetes can damage nerves. High blood glucose levels can also damage the small blood vessels that nourish nerves with oxygen and nutrients.

Symptoms of diabetic neuropathy includes loss of sensation in their feet, burning or shooting pain in their lower legs, muscle weakness or wasting, bladder problems such as incomplete bladder emptying, vision trouble such as double vision.

Doctors most often diagnose diabetic neuropathy by asking about symptoms and physical examination. The tests include filament test, sensory test, nerve conduction test, autonomic test, and electromyography.

The most common investigative treatments include anti-seizure drugs, antidepressants to ease pain. Symptoms can be eased through lifestyle changes and home remedies like physically active, follow diabetes meal plan, quit smoking, and limit alcoholic drinks to no more than one drink per day.

Report Highlights

Global Insight Service’s, Diabetic Neuropathy – Drug Pipeline Landscape, 2022 report provides an overview of the Diabetic Neuropathy pipeline drugs. This report covers detailed insights on Diabetic Neuropathy drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Diabetic Neuropathy pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Micro Surgical Robot Market
November, 2022

The global micro surgical robot market was valued at USD 1,280 million in 2021 and it is anticipated to grow further till USD 4,766.2 million by 2031, at a CAGR of 14.1% during the forecast period.

Robotic surgery, commonly referred to as robot-assisted surgery, enables medical professionals to carry out a variety of complex procedures with more accuracy, adaptability, and control than is possible with conventional methods. The most frequent association of robotic surgery is with minimally invasive procedures done through tiny incisions. It is occasionally used in classic open surgical procedures. Magnification, sophisticated diploscopes, specialized precision equipment, and a range of operating procedures are all used in the surgical specialty of microsurgery. These procedures are mostly used to coapt nerves and anastomose small blood vessels (veins and arteries).

Global Micro Surgical Robot Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 1,280 Million
Market Size in 2031US$ 4,766.2 Million
CAGR %14.1%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredApplication, End User, and Region
Key CompaniesStryker, Corindus Inc (Siemens Healthineers), Medtronic, Intuitive Surgical, Meerecompany, Smith & Nephew, Medrobotics corporation, Auris Health (Johnson & Johnson), Zimmer Biomet, Titan Medical, and TransEnterix Surgical among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Compared to other surgical approaches, minimally invasive surgeries have a variety of benefits, including fewer complications from minor incisions, less discomfort and scarring, and shorter hospital stays. Robotic microsurgeries are low-risk procedures that can reduce surgical site infections. The robotic system’s micro instruments enable surgical involvement through a tiny incision, which is otherwise impossible with manual surgery. Additionally, the easy access to micro tools is encouraging other major manufacturers to enter the market for microsurgery robots.

Market Restraints and Challenges

However, as hospitals prioritise COVID-19 patients, there has been a decrease in the number of procedures conducted as a result of COVID-19. Due to its restricted applicability, this may temporarily reduce demand for microsurgery robots.

Global Micro Surgical Robot Market Segmental Overview

The report analyses the global micro surgical robot market based on the application, end user, and region.

Global Micro Surgical Robot Market by Application

Based on the application, it is segmented into urology surgery, plastic reconstructive surgery, ophthalmic surgery, neurosurgery, lymphatic surgery, ENT surgery, and others. The urology segment is anticipated to dominate the market during the forecast period. Due to the increasing prevalence of urological illnesses and the availability of microsurgery robots for the treatment of urology-related surgeries, the urology segment held the dominant position. The use of microsurgery robots in urological diseases has increased due to their ability to stop blood loss and shorten recovery times. The market demand will also be fueled by the high precision offered by microsurgery robots as well as improved patient outcomes due to the absence of tremors.

Global Micro Surgical Robot Market by End User

Based on the end user, it is segmented into hospitals & clinics, ambulatory surgical centers, research centers, and others. The hospitals & clinics is anticipated to dominate the market during the forecast period. The market will increase as a result of the availability of cutting-edge infrastructure and intensive medical care for the treatment of numerous chronic illnesses. Additionally, governmental hospitals and clinics are providing improved reimbursement policies for surgical treatments, which will further drive the market’s growth. Furthermore, the advancement of the industry is accelerated by the presence of qualified healthcare professionals in hospitals. The market demand will also be fueled by an increasing emphasis on performing procedures with more precision and providing greater comfort for doctors.

Geographical Analysis of the Global Micro Surgical Robot Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North America region is anticipated to dominate the market during the forecast period. Due to increased regional deployment of surgical robots and rising R&D funding for microsurgery robots. Six out of ten persons in the United States, according to the Centers for Disease Control and Prevention (CDC), suffer from chronic conditions. As a result, the American population will increasingly need microsurgery robots due to the rise in chronic diseases like cancer, heart disease, diabetes, and others. The growth of the regional industry will also be aided by the presence of well-known market players in North America that offer microsurgery robot devices for better patient access and care.

Major Players in the Global Micro Surgical Robot Market

The report analyses the major players such as Stryker, Corindus Inc (Siemens Healthineers), Medtronic, Intuitive Surgical, Meerecompany, Smith & Nephew, Medrobotics corporation, Auris Health (Johnson & Johnson), Zimmer Biomet, Titan Medical, and TransEnterix Surgical among others.

COVID-19 Impact

The COVID-19 epidemic has had a severe negative impact on society and the economy. Numerous organization’s supply chains and value chains have been impacted by the pandemic. The market for microsurgical robots is typical. On the basis of the entire industry, taking into account both the demand side and supply side viewpoints, the impact of the COVID-19 pandemic will be examined. The pandemic’s consequences would be researched and examined for both short- and long-term situations. This will help all industry participants, including suppliers, manufacturers, vendors, distributors, and end-users, to develop business strategies for the time during the pandemic as well as the time after the pandemic.

Recent Developments
  • April 2022, SS Innovations launched its SSI multi-arm revolutionary telerobotic assistance surgical system in India for US$0.54 to US$ 0.68 million (INR 40-50 million).
  • July 2020, Smith & Nephew announced the launch of hand-held robotic platform for knee replacement surgery. This strategy will assist the company in enhancing its product portfolio in the global industry.
  • March 2018, Stryker’s joint replacement division launched the next generation Trident II Acetabular System with the accuracy of Mako Robotic-Arm Assisted Surgery. This new product launch helped the company in expanding its product portfolio and enhanced its market share.
Frequently Asked Questions

Q1. How big is the Micro Surgical Robot market?

Ans. The global Micro Surgical Robot market size was USD 1,280 million in 2021 and it is anticipated to grow further till USD 4,766.2 million by 2031, at a CAGR of 14.1% from 2022 to 2031.

Q2. What is the Micro Surgical Robot market growth rate?

Ans. The growth rate of the Micro Surgical Robot market is 14.1%.

Q3. Which region holds a major market share for the Micro Surgical Robot market?

Ans. North America holds a major market share of the Micro Surgical Robot market in 2021.

Q4. Which segment accounted for the largest Micro Surgical Robot market share?

Ans. By end user, the hospitals segment accounted for the largest Micro Surgical Robot market share.

Q5. Who are the key players in the Micro Surgical Robot market?

Ans. The global Micro Surgical Robot market report includes players such as Stryker, Corindus Inc (Siemens Healthineers), Medtronic, Intuitive Surgical, Meerecompany, Smith & Nephew, Medrobotics corporation, Auris Health (Johnson & Johnson), Zimmer Biomet, Titan Medical, and TransEnterix Surgical among others.

Q6. What are the factors driving the Micro Surgical Robot market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Micro Surgical Robot market players?

Ans. The key growth strategies of Micro Surgical Robot market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Micro Surgical Robot market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Micro Surgical Robot market during the forecast period.

 

Read More
Single User License

Soft Tissue Anchors Market
November, 2022

The global soft tissue anchors market was valued at USD 677.7 million in 2021 and it is anticipated to grow further till USD 1,228.1 million by 2031, at a CAGR of 6.1% during the forecast period.

Orthopedic surgery frequently makes use of soft tissue anchors. An orthopaedic injury may develop as a result of sudden trauma or constant mobility. The main causes of fractures and injuries to the bones are sports and strenuous physical activity.

Global Soft Tissue Anchors Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 677.7 Million
Market Size in 2031US$ 1,288.1 Million
CAGR %6.1%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Material, Typing Type, End User, and Region
Key CompaniesSmith & Nephew plc, Zimmer Biomet Holdings, Inc., ConMed Corporation, Arthrex, Inc, Johnson and Johnson (DePuy Synthes, Inc.), Medtronic plc, Stryker Corporation, Parcus Medical, LLC., Wright Medical Group N.V., Teknimed SA, MedShape, Inc., Anstem Medical, Groupe Lepine S.A., Neosys Surgical Solutions LTD and Biocomposites Ltd among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The market for soft tissue anchors is expected to rise as more sports injuries require orthopedic treatment, such as rotator cuff surgery, torn ligament repairs, removal of loose bones or cartilages, etc. A common injury among sportsmen is shoulder dislocation, which, if not properly treated, can lead to irreversible damage. The most popular and least invasive method for treating shoulder dislocation is called arthroscopic bank art repair, which uses soft tissue anchors.

Market Restraints and Challenges

The high cost of surgeries coupled with unfavorable reimbursement scenario are hindering the growth of the market.

Global Soft Tissue Anchors Market Segmental Overview

The report analyses the global soft tissue anchors market based on the product, typing type, material, end user, and region.

Global Soft Tissue Anchors Market by Product

Based on product, it is segmented into absorbable soft tissue anchors and non-absorbable soft tissue anchors. The absorbable soft tissue anchors segment is anticipated to dominate the market during the forecast period. Soft tissue anchors are widely used in orthopedic surgeries. An orthopedic injury may occur owing to acurate trauma or repetitive motion of the body.

Global Soft Tissue Anchors Market by Typing Type

Based on typing type, it is segmented into knotless suture anchors and knotted suture anchors. The knotless suture anchors segment is anticipated to dominate the market during the forecast period. The increasing number of sports injuries and orthopedic surgeries is boosting the growth of the market.

Global Soft Tissue Anchors Market by Material

Based on the material, it is segmented into metallic suture anchor, bio-absorbable suture anchor, PEEK suture anchor, bio-composite suture anchor, and others. The metallic suture anchor segment is anticipated to dominate the market during the forecast period. The increasing geriatric population is highly prone to various orthopedic conditions such as joint disorders, anterior cruciate ligament injuries, joint fusion, osteoarthritis, and others.

Global Soft Tissue Anchors Market by End User

Based on the end user, it is segmented into hospitals, clinics, emergency medical services, and other. The hospital segment is anticipated to dominate the market during the forecast period. Obesity and osteoporosis are two prevalent disorders whose incidence is rising. Obese patients are more prone to have specific orthopedic issues, which heighten the need for surgery.

Geographical Analysis of the Global Soft Tissue Anchors Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Suture anchor demand is expected to increase due to the rising prevalence and incidence of orthopaedic injuries in the world’s population. The worldwide suture anchor market is primarily driven by ongoing developments, technological improvements, declining healthcare costs, and the development of new suture anchor components. Additionally, growing investments in the creation of novel kinds of suture anchors offer an efficient choice for treating orthopedic injuries, which is fueling market expansion.

Major Players in the Global Soft Tissue Anchors Market

The key players studied in the global soft tissue anchors market are Smith & Nephew plc, Zimmer Biomet Holdings, Inc., ConMed Corporation, Arthrex, Inc, Johnson and Johnson (DePuy Synthes, Inc.), Medtronic plc, Stryker Corporation, Parcus Medical, LLC., Wright Medical Group N.V., Teknimed SA, MedShape, Inc., Anstem Medical, Groupe Lepine S.A., Neosys Surgical Solutions LTD and Biocomposites Ltd among others.

COVID-19 Impact

Numerous COVID-19 patients, many of whom are in severe condition, have overrun most hospitals in Europe and the United States. The treatment of these individuals has forced medical professionals to put off less urgent surgeries. Furthermore, the supply chains for soft tissue anchors are being disrupted by governments’ strict lockdowns. The pandemic has presented hurdles for manufacturers, and their financial situation has been badly impacted. However, the market will resume steady expansion by the third quarter of 2020 thanks to partnerships with other sector titans and governmental bodies.

Recent Developments
  • August 2022, MedTech innovator and OurCrowd portfolio company Ossio launched its proprietary Suture Anchors for orthopedic surgery in the US.
  • June 2022, Anika Therapeutics Inc. has announced FDA 510(k) clearance of the X-Twist knotless fixation system for soft tissue repairs in the shoulder, foot and ankle and other extremities.
  • May 2022, Paragon 28 Expands soft tissue portfolio with Grappler suture anchor system launch. The Grappler Suture Anchor System provides surgeons with an alternative fixation option designed to limit implant migration and loss of tension for intraoperative tissue reattachment and fixation in the foot and ankle.
  • March 2022, Ossio announced today that it received the third FDA clearance for its OssioFiber product family.
Frequently Asked Questions

Q1. How big is the Soft Tissue Anchors market?

Ans. The global Soft Tissue Anchors market size was USD 677.7 million in 2021 and it is anticipated to grow further till USD 1,228.1 million by 2031, at a CAGR of 6.1% from 2022 to 2031.

Q2. What is the Soft Tissue Anchors market growth rate?

Ans. The growth rate of the Soft Tissue Anchors market is 6.1%.

Q3. Which region holds a major market share for the Soft Tissue Anchors market?

Ans. North America holds a major market share of the Soft Tissue Anchors market in 2021.

Q4. Which segment accounted for the largest Soft Tissue Anchors market share?

Ans. By end user, the hospitals segment accounted for the largest Soft Tissue Anchors market share.

Q5. Who are the key players in the Soft Tissue Anchors market?

Ans. The global Soft Tissue Anchors market report includes players such as Smith & Nephew plc, Zimmer Biomet Holdings, Inc., ConMed Corporation, Arthrex, Inc, Johnson and Johnson (DePuy Synthes, Inc.), Medtronic plc, Stryker Corporation, Parcus Medical, LLC., Wright Medical Group N.V., Teknimed SA, MedShape, Inc., Anstem Medical, Groupe Lepine S.A., Neosys Surgical Solutions LTD and Biocomposites Ltd among others.

Q6. What are the factors driving the Soft Tissue Anchors market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Soft Tissue Anchors market players?

Ans. The key growth strategies of Soft Tissue Anchors market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Soft Tissue Anchors market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Soft Tissue Anchors market during the forecast period.

Read More
Single User License

Automatic Pill Dispenser Market
November, 2022

The global automatic pill dispenser market was valued at USD 2.3 Billion in 2021 and it is anticipated to grow up to USD 6.3 Billion by 2031, at a CAGR of 10.6% during the forecast period.

An automatic pill dispenser is a device that stores and dispenses medication in pre-set doses. It is typically used by people who take multiple medications or who have difficulty remembering to take their medication. The dispenser is programmed to dispense the correct amount of medication at the correct time. It can be used with or without supervision.

Global Automatic Pill Dispenser Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$2.3 bn
Market Size in 2031$6.3bn
Growth Rate (2021-31)10.6%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, End-user, and Region
Key CompaniesBaxter International Inc., Becton, Dickinson and Company, Cerner Corporation, Capsa Healthcare, McKesson Corporation, Omnicell Inc., ScriptPro LLC, Swisslog Holdings AG, Talyst, Inc. and Yuyama Co., Ltd.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Recent technological advances in automatic pill dispensers are expected to drive the industry in the near future. The introduction of automatic pill dispensers connected with barcode scanning allows for precise medicine delivery while also preventing the loading of incorrect medication and providing additional safety precautions for high-risk pharmaceuticals. The bluetooth connectivity enables customers to connect these gadgets to any compatible device, including phones, to receive visual and audible notifications, so favourably pushing industrial expansion. These gadgets now come with a digital detachable timer, which is ideal for people with memory or cognitive problems who require frequent reminders to take medications. As a result of the introduction of unique devices that allow users to select the schedules to dispense numerous medications at the needed times, the industry demand is expanding dramatically.

Market Restraints and Challenges

Stringent government rules and errors caused by automatic pill dispensers may have a detrimental impact on industry growth. A programming error in automatic pill dispensers may result in lower patient satisfaction and a growing distrust of healthcare facilities. Incorrect programming of clever pumps and IVs is a major worry for chronic disease patients and can have serious consequences for their overall health. The FDA monitors the approval and use of this device because of the significant risk associated with its use in chronically sick patients. These devices are designated as class I devices, which require reasonable assurance of the device’s safety and effectiveness.

Global Automatic Pill Dispenser Market Segmental Overview

The report analyses the global Automatic Pill Dispenser market based on product, end-user, and region

Global Automatic Pill Dispenser Market by Product

Based on product, the market is segmented as Centralized Automated Dispenser, and Decentralized Automated Dispenser. Among them centralized automated dispenser segment in the Automatic Pill Dispenser market is projected to witness significant growth rate through 2031. This is due to the several benefits comprising optimize medication storage, improves staff productivity, and reduce medication errors among others. Centralized automatic systems have a user in direct control of the dispensing method. A robotic centralized automatic dispenser organizes a large number of drugs without the need for any human intervention, enhances pharmaceutical operations, and provides security, thereby decreases chances of error or medicine theft considerably.

Furthermore, as compared to manual processes, these systems can fill over 1,000 prescriptions per hour, greatly reducing patient waiting time and contributing to improved patient satisfaction. This can considerably prevent cross contamination and infection caused by improperly handled prescription medicines or germ exposure. As a result, the centralised automatic dispenser’s capabilities, as well as continual innovation and improvement in this device, are expected to considerably fuel the automatic pill dispenser market expansion over the forecast period.

Global Automatic Pill Dispenser Market by End-user

Based on end-user, the market is segmented as hospitals, pharmacies, senior care, and others. The hospital segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2031. An automatic pill dispenser in a hospital provides a medication management system that maintains drugs neatly organised and secure, driving the industry size. These systems can manage each user’s access to stored drugs based on individual permissions and automatically document and trace all transactions. The computerised automatic pill dispenser used in hospitals is an advanced system for full drug dispensing process management that eliminates human mistake, subtracts the drug from the central inventory in real-time, and updates clinical case records.

Geographical Analysis of Global Automatic Pill Dispenser Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America held significant market share in 2021. This is due to the variety of variables such as an ageing population and an increase in the prevalence of chronic diseases. In 2019, the number of adults aged 45-64 in the United States climbed to 83.3 million. According to the American Heart Association, over 43.7 million persons aged 60 and up had one or more forms of cardiovascular illnesses in 2016. This figure reflects the increasing number of patients admitted to hospitals and the increasing strain on the old pharmaceutical system, consequently raising the regional industry growth.

Major Players in the Global Automatic Pill Dispenser Market

The key players in the market Baxter International Inc.BectonDickinson and CompanyCerner CorporationCapsa HealthcareMcKesson CorporationOmnicell Inc.ScriptPro LLCSwisslog Holdings AGTalyst, Inc. and Yuyama Co., Ltd. among others.

COVID-19 Impact

The COVID-19 was an unusual public health concern that caused financial difficulties, social disturbance, and had a substantial impact on the worldwide economy. This pandemic has both indirect and direct negative effects on the automatic pill dispenser business in 2020. The coronavirus outbreak required substantial adjustments in the healthcare business, hampered medical personnel’ regular operations, and limited hospital admissions. Non-emergent hospital appointments for various disease treatments were referred to as such. Because the majority of outpatient visits were deemed voluntary, it was recommended that all non-urgent visits be cancelled, considering the risk of transmission. The outbreak of coronavirus had caused an interruption in logistics & supply chain and forced the government bodies to implement travel limitations that restricted the movement of goods, thereby obstructing the industry growth.

Recent Developments
  • In December 2021, Hero and AdhereHealth entered a strategic partnership. Hero’s platform includes a connected smart pill dispenser, which automatically sorts and dispenses medications according to a patient’s unique medication schedule. This partnership has led to simultaneously improving patient safety by focusing on medication management, further supporting caregivers, and helping people take more control of their health.
  • In July 2021, Big Sky Labs has raised $1 million in seed funding to develop a device to dispense medications and provide other home health services such as wellness checks and health monitoring. The device, called PillPez, dispenses medications at specified times during the day from pre-loaded medication strips available from most pharmacies. If an individual does not take the drugs, PillPez provides an escalating set of reminders, including to caregivers or family.
  • In March 2021, Accelmed Partners announced that it led a $40 million investment in MedMinder Systems Inc., to further expand the Companys geographic footprint, integrate new telemedicine technologies, and serve a larger U.S. customer base.”
  • In December 2020, Capsa Healthcare announced a significant development in its NexsysADC product line, the addition of new auxiliary cabinets of up to 10 tiers that will help to expand storage and supplies of medication doses significantly.
Frequently Asked Questions

Q1. How big is the Automatic Pill Dispenser market?

Ans. The global automatic pill dispenser market was valued at USD 2.3 Billion in 2021 and it is anticipated to grow up to USD 6.3 Billion by 2031, at a CAGR of 10.6% during the forecast period.

Q2. What is the automatic pill dispenser market growth rate?

Ans. The growth rate of the automatic pill dispenser market is 10.6%.

Q3. Which region holds a major automatic pill dispenser market share for the market?

Ans. North America holds a major market share of the automatic pill dispenser market in 2021.

Q4. Which segment accounted for the largest automatic pill dispenser market share?

Ans. By application the home healthcare segment accounted for the largest automatic pill dispenser market share.

Q5. Who are the key players in the automatic pill dispenser market?

Ans. The global automatic pill dispenser market report includes players such as Baxter International Inc.BectonDickinson and CompanyCerner CorporationCapsa HealthcareMcKesson CorporationOmnicell Inc.ScriptPro LLCSwisslog Holdings AGTalyst, Inc. and Yuyama Co., Ltd. among others.

Q6. What are the factors driving the automatic pill dispenser market growth?

Ans. The major factors driving the growth of the market are advantages offered by automatic pill dispensers along with rise in geriatric population.

Q7. What are the key growth strategies of automatic pill dispenser market players?

Ans. The key growth strategies of automatic pill dispenser market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the automatic pill dispenser market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the automatic pill dispenser market during the forecast period.

Read More
Single User License

Laser Therapy Devices Market
November, 2022

The global laser therapy devices market was valued at USD 2.3 Billion in 2021 and it is anticipated to grow up to USD 5.8 Billion by 2031, at a CAGR of 9.7% during the forecast period.

Laser therapy devices are used to treat a variety of conditions and injuries by delivering concentrated light energy to the target area. The light energy from the laser interacts with tissue and creates a biological response that reduces inflammation, pain, and promotes healing. Laser therapy is a non-invasive, pain-free treatment option that is FDA-cleared and clinically proven to be effective.

Global Laser Therapy Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$2.3bn
Market Size in 2031$5.8 bn
Growth Rate (2021-31)9.7%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Application, End-user, and Region
Key CompaniesBoston Scientific Corporation, IPG Photonics Corporation, Lumenis Ltd., Coherent Inc., Biolitec AG, Hologic Inc., Alma Lasers Ltd., Fotona D.D, Danaher Corporation, and Thermo Fisher Scientific Inc.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Rising consumer preference for innovative and non-invasive laser based technologies will foster the demand for laser therapies across the globe. Increasing number of geriatric population will further induce inn the demand for this technology as it helps to reduce pain and inflammation in the body. Rising eye disorders too will bolster the laser therapy market growth. Increase in the personal disposable income and increased demand for cosmetic surgeries will further create more lucrative opportunities for growth of laser therapy market.

Market Restraints and Challenges

High costs involved in the installation and maintenance of the technology will dampen the growth of the market. Further, stringent regulations imposed by the government on the acquisition and installation of the technology will slow down the market growth rate. High rate of failure of laser based surgical procedures coupled with the side effects of undergoing a laser therapy will further come as an obstruction in the way of growth of the market.

Global Laser Therapy Devices Market Segmental Overview

The report analyses the global Laser Therapy Devices market based on product, application, end-user, and region.

Global Laser Therapy Devices Market by Product

By product, the market is segmented into gas laser systems, liquid/dye laser systems, semiconductor/diode laser systems, and others. The liquid/dye laser system segment accounted for the largest share of the global revenue in 2021, owing to the wide usage of these products on account of their rapid treatment results. They have proven to be safer for all skin tones & hair colors and facilitate less painful treatment procedures. With technological advancements, these products are expected to dominate the market even during the forecast period. Laser devices are sub-segmented into Nd: YAG, diode, and alexandrite laser systems.

Global Laser Therapy Devices Market by Application

By application, the laser therapy devices market is classified into dermatology, cardiovascular, oncology, and others. The ophthalmology segment is estimated to register considerable expansion through 2031. This is because ophthalmic lasers enable the precise treatment of an array of eye issues with minimal risk of infection. It is noteworthy that a number of laser processes are relatively pain free and can be performed on an outpatient basis. Besides, these provide the advantages of relatively low cost, high accuracy, and safety and essentially destroy the targeted tissue for a beneficial impact on the eye. These aspects are expected to propel the usage of laser therapy for eyes during the forecast period.

Global Laser Therapy Devices Market by End-user

The end-user segment of the market is bifurcated into Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Others. The hospitals segment is projected to account for a lucrative share in the laser therapy devices market by 2028. This growth is attributed to the availability of innovative and advanced technology-based laser devices in these settings. The product demand is further slated to rise with an increase in hospitalizations for complex procedures such as cancer-related processes and cardiovascular disorders. The availability of favorable reimbursement policies and improving hospital infrastructure are poised to boost the market expansion through the analysis period.

Geographical Analysis of Global Laser Therapy Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Laser Therapy Devices market revenue is poised to grow significant CAGR during the forthcoming years. This is owing to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, a major medical solutions company, has been awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent will cover particular laser devices that will be manufactured by the company and sold in the veterinary and medical markets.

Major Players in the Global Laser Therapy Devices Market

The key players in the Laser Therapy Devices market s Boston Scientific Corporation, IPG Photonics Corporation, Lumenis Ltd., Coherent Inc., Biolitec AG, Hologic Inc., Alma Lasers Ltd., Fotona D.D, Danaher Corporation, and Thermo Fisher Scientific Inc., among others.

COVID-19 Impact

The COVID-19 pandemic has led to an increase in studies that help in assessing the usefulness of laser therapy in the treatment of the disease. For instance, October 2020 witnessed the publication of a second case report which demonstrated positive outcomes for a SARS-CoV-2 patient treated with laser therapy. Published in the Canadian Journal of Respiratory Therapy, the article describes a remarkable reduction in inflammatory markers, Ferratin and IL-6, and marked improvement in radiological findings post supportive treatment with PBMT (Photobiomodulation Therapy). Similar studies are expected to impel the development of advanced laser therapy devices through the coming years.

Recent Developments
  • In October 2022, Dexcom has begun the global rollout of its G7 continuous glucose monitoring system by making the device available in the U.K., Ireland, Germany, Austria and Hong Kong. The device is designed to be smaller, easier to use and have a better mobile application than its predecessor, while also powering up faster than rival CGM systems. Still the U.S. launch has been delayed, until late 2022.
  • In August 2022, Teladoc Health, the announced the addition of a home A1C testing program to its Livongo by Teladoc Health chronic care solution, making it easier for members to manage and control their diabetes
  • In September 2021, Know Labs Inc, a US-based company that manufactures glucose monitoring devices launched a new portable medical-grade glucose monitoring device named KnowU that utilizes Bio-RFID technology. This device is a non-invasive glucose monitoring machine that has a base that powers the device and displays readings and, a battery a powered monitor with Bio-RFID sensors that can be carried by the users to check sugar levels on the go.
  • In May 2021, Roche collaborated with Eli Lilly and Company, to work towards enhancing the management of insulin pen therapy. With this collaboration, Roche follows its ambition to create an open ecosystem including its own and partner devices, solutions, and services, across the continuum of care in diabetes.
Frequently Asked Questions

Q1. How big is the laser therapy devices market?

Ans. The global laser therapy devices market was valued at USD 2.3 Billion in 2021 and it is anticipated to grow up to USD 5.8 Billion by 2031, at a CAGR of 9.7% during the forecast period.

Q2. What is the laser therapy devices market growth rate?

Ans. The growth rate of the laser therapy devices market is 9.7%

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the laser therapy devices market in 2021.

Q4. Which segment accounted for the largest laser therapy devices market share?

Ans. By end-user, the hospital segment accounted for the largest Laser Therapy Devices market share.

Q5. Who are the key players in the laser therapy devices market?

Ans. The global laser therapy devices market report includes players such s Boston Scientific Corporation, IPG Photonics Corporation, Lumenis Ltd., Coherent Inc., Biolitec AG, Hologic Inc., Alma Lasers Ltd., Fotona D.D, Danaher Corporation, and Thermo Fisher Scientific Inc., among others.

Q6. What are the factors driving the laser therapy devices market growth?

Ans. The major factors driving the growth of the market are growing adoption of cold laser therapy for the stimulation of healing by using low levels of light.

Q7. What are the key growth strategies of laser therapy devices market players?

Ans. The key growth strategies of Self laser therapy devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the laser therapy devices market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the laser therapy devices market during the forecast period.

Read More
Single User License

Brain Cancer Diagnostics Market
November, 2022

The global brain cancer diagnostics market was valued at USD 1639.1 million in 2021 and it is anticipated to grow further till USD 20116.4 million by 2031, at a CAGR of 28.5% during the forecast period.

Extracellular growth in the brain, such as primary and secondary brain tumors, is referred to as brain cancer. While secondary tumors or metastases are those that are brought on by cancers that started in another region of the body, primary brain tumors originate in the brain and do not spread to other parts of the body. There are 40 different varieties of brain tumors that can be classified, and these types are divided into two main categories: benign tumors, which are slow-growing and less prone to spread, and cancerous tumors, which are more likely to do so. There are various factors that lead to brain cancer and are more prevalent in people with particular hereditary or gene disorders.

Global Brain Cancer Diagnostics Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 1639.1 Million
Market Size in 2031US$ 20116.4 Million
CAGR %28.5%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredTest Type, Cancer Type, End User, and Region
Key CompaniesTHERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd, and Neusoft Medical Systems among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

It is anticipated that factors like technological breakthroughs from traditional procedures will fuel revenue growth in the brain cancer diagnostics market. The diagnostic equipment’s speed and accuracy have both increased as a result, producing improved results that may finally allow for the earlier use of medicines. Global brain cancer prevalence is predicted to significantly rise in the coming years, supporting market expansion. Increased cigarette smoking and other environmental pollutants, which cause brain cancer, are one of the main contributing factors. This year, there are projected to be 78,000 new primary brain tumour diagnoses, of which 53,000 are non-malignant and 25,000 are malignant.

Market Restraints and Challenges

The main obstacles are the escalating expense of diagnosis, the lack of awareness, and the limited accessibility to the same. In this aspect, affluent markets have substantially greater diagnostic rates than low-income nations.

Global Brain Cancer Diagnostics Market Segmental Overview

The report analyses the global brain cancer diagnostics market based on the test type, cancer type, end user, and region.

Global Brain Cancer Diagnostics Market by Test Type

Based on the test type, it is segmented into magnetic resonance spectroscopy, PET scan, single photon emission CT scan, spinal tap, and magnetic resonance imaging. The magnetic resonance spectroscopy segment is anticipated to dominate the market during the forecast period. The market size of the segment has been impacted by the increase in cigarette smokers who are at risk of developing brain cancer. However, significant obstacles include high diagnostic costs, little awareness, and limited accessibility.

Global Brain Cancer Diagnostics Market by Cancer Type

Based on Cancer type, it is segmented into the acoustic neuroma, astrocytoma, chordoma, and ependymomas. The acoustic neuroma segment is anticipated to dominate the market during the forecast period. Deep learning is a subset of artificial intelligence that “trains” convolutional neural networks, which are sophisticated mathematical algorithms, to extract features from data. The system can recognize patterns and carry out tasks like picture analysis thanks to this training. The researchers started to run algorithm training on the brain tumor tissue images generated by the SRH imager to combine the potent capabilities of the SRH imager with AI.

Global Brain Cancer Diagnostics Market by End User

Based on the end user, it is segmented into hospitals, cancer diagnostic center, and cancer research institutes. The hospitals segment is anticipated to dominate the market during the forecast period. Technological advancements and advancements in diagnostic equipment are predicted to be the market size drivers for the expansion of brain cancer diagnostics. Additionally, in the approaching years, the significance of the growth in brain cancer is anticipated to increase on a global scale.

Geographical Analysis of the Global Brain Cancer Diagnostics Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Due to the availability of reimbursement facilities, increased diagnostic rates are anticipated across Eastern and Western Europe. The market for brain cancer diagnostics is anticipated to benefit from an increase in the quality of healthcare services in Asia Pacific nations. The rise in healthcare costs brought on by government spending plans may raise the bar for diagnostic infrastructure in Asia Pacific nations. China, India, Australia, New Zealand, and South Korea are among the Asian nations that are anticipated to show the most promise due to increased per capita healthcare spending and significant infrastructure improvements.

Major Players in the Global Brain Cancer Diagnostics Market

The key players studied in the report are THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd, and Neusoft Medical Systems among others.

COVID-19 Impact

Resources for people with diseases like cancer were diverted by the COVID-19 epidemic. At the start of the COVID-19 crisis, the market for brain cancer diagnostics saw some shortages as a result of factors such supply chain disruption and demand due to the absence of lockdown indicated by the majority of governments. The COVID-19 pandemic had a detrimental effect on cancer patients since so many of them were immunosuppressed and elderly. Additionally, several clinics globally experienced delays with cancer follow-up or imaging appointments. Delays in new cancer diagnosis were caused by delaying normal screening exams. The COVID-19 pandemic caused a delay in cancer detection, which led to a rise in cancer-related death.

Frequently Asked Questions

Q1. How big is the Brain Cancer Diagnostics market?

Ans. The global Brain Cancer Diagnostics market size was USD 1639.1 million in 2021 and it is anticipated to grow further till USD 20116.4 million by 2031, at a CAGR of 28.5% from 2022 to 2031.

Q2. What is the Brain Cancer Diagnostics market growth rate?

Ans. The growth rate of the Brain Cancer Diagnostics market is 28.5%.

Q3. Which region holds a major market share for the Brain Cancer Diagnostics market?

Ans. North America holds a major market share of the Brain Cancer Diagnostics market in 2021.

Q4. Which segment accounted for the largest Brain Cancer Diagnostics market share?

Ans. By end user, the hospitals segment accounted for the largest Brain Cancer Diagnostics market share.

Q5. Who are the key players in the Brain Cancer Diagnostics market?

Ans. The global Brain Cancer Diagnostics market report includes players such as THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd, and Neusoft Medical Systems among others.

Q6. What are the factors driving the Brain Cancer Diagnostics market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Brain Cancer Diagnostics market players?

Ans. The key growth strategies of Brain Cancer Diagnostics market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Brain Cancer Diagnostics market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Brain Cancer Diagnostics market during the forecast period.

Read More
Single User License

Self-Monitoring Blood Glucose Devices Market
November, 2022

The global Self-Monitoring Blood Glucose Devices market was valued at USD 18.9 Billion in 2021 and it is anticipated to grow up to USD 45.8 Billion by 2031, at a CAGR of 9.3% during the forecast period.

A self-monitoring blood glucose device is a portable machine that helps people with diabetes check their blood sugar levels. The device usually consists of a small monitor and a lancet, which is a small, sharp needle used to prick the skin and draw a drop of blood. The blood is then placed on a test strip, which is inserted into the monitor. The monitor displays the blood sugar level on a screen. Self-monitoring blood glucose devices are important tools for people with diabetes. They help people to keep track of their blood sugar levels and to make sure that they are staying within their target range. self-monitoring also allows people to see how their diet and exercise are affecting their blood sugar levels.

Global Self-Monitoring Blood Glucose Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$18.9 bn
Market Size in 2031$45.8bn
Growth Rate (2021-31)9.3%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Application, Distribution Channel and Region
Key CompaniesAbbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings, LL, PHC Holdings Corporation, Terumo Corporation, Trividia Health, Inc. (Sinocare Inc.), ARKRAY, Inc. and Ypsomed Holding AG.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Growing awareness regarding home monitoring and focus on regular diabetes management to reduce risk of hyperglycemic conditions has led to growing demand for self-monitoring blood glucose devices. Additionally, government is undertaking several initiatives to increase awareness among people regarding early diagnosis. The National Diabetes Education Program (NDEP) is the joint effort of the National Institutes of Health and Centers for Disease Control and Prevention (CDC). NDEP aims at reducing burden of prediabetes by providing diabetes-related education to a range of people such as hard-to-reach population, ethnic minorities, faith-based organizations, community-based organizations, and healthcare providers. Such factors are boosting the adoption rate of Self-Monitoring Blood Glucose Devices contributing to the overall market expansion.

Market Restraints and Challenges

There are a few key restraints and challenges in the self-monitoring blood glucose devices market. Firstly, these devices can be expensive, and patients may not be able to afford them. Secondly, some patients may find it difficult to use these devices, and may need training or assistance. Finally, some patients may not want to self-monitor their blood glucose levels, and may prefer to rely on other methods, such as finger-pricking.

Global Self-Monitoring Blood Glucose Devices Market Segmental Overview

The report analyses the global Self-Monitoring Blood Glucose Devices market based on product, application, distribution channel, and region.

Global Self-Monitoring Blood Glucose Devices Market by Product

By product, the market is segmented into Self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. The continuous glucose monitors segment accounted for significant market share in 2021 and is expected to register lucrative CAGR over the forecast period. CGMs are witnessing robust advances along with several novel launches by prominent firms. In addition, demand for continuous glucose monitoring devices increased during the COVID-19 pandemic. Moreover, rising demand for user-friendly homecare devices coupled with accessibility of various advanced continuous glucose monitoring devices in the market will impel the segment growth.

Global Self-Monitoring Blood Glucose Devices Market by Application

By application, the Self-Monitoring Blood Glucose Devices market is classified into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 2 diabetes segment accounted for significant revenue in 2021. Lifestyle changes such as adoption of an unhealthy and sedentary lifestyle are observed to be some of the prominent factors leading to the high prevalence of diabetes. Growing obese population, physical inactiveness and consumption of unhealthy diet leads to increased risk of type 2 diabetes. Further, SMBG devices help type 2 diabetes patients to keep timely track of glycerine level in the body.

Global Self-Monitoring Blood Glucose Devices Market by Distribution Channel

The distribution channel segment of the market is bifurcated into hospital pharmacies, retail pharmacies, online sales, and diabetes clinics & centers. The hospital pharmacies are expected to register highest CAGR between 2022 and 2028. Growing government funding in developing and developed regions in order to establish advanced healthcare facilities will contribute to the segment expansion. Furthermore, rising geriatric population that is more susceptible to suffer from diabetes increases hospitalizations and patient visits that is further slated to boost the segment progression during the forecast period.

Geographical Analysis of Global Self-Monitoring Blood Glucose Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Self-Monitoring Blood Glucose Devices market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the high prevalence of diabetes and rising healthcare expenditure. According to the CDC, in 2020, 34.2 million Americans were suffering from diabetes, and one per 3 Americans had prediabetes. Obesity, unhealthy dietary habits and other environmental factors further increases the patient base. Additionally, numerous efforts undertaken by government and international organizations to reduce disease burden will drive the industry growth during the forecast timeframe.

Major Players in the Global Self-Monitoring Blood Glucose Devices Market

The key players in the Self-Monitoring Blood Glucose Devices market Abbott LaboratoriesBionime CorporationB. Braun Melsungen AGF. Hoffmann-La Roche Ltd.LifeScan IP Holdings, LL, PHC Holdings CorporationTerumo Corporation, Trividia Health, Inc. (Sinocare Inc.)ARKRAY, Inc. and Ypsomed Holding AG., among others.

COVID-19 Impact

The outbreak of COVID-19 pandemic had a negative impact on the Self-Monitoring Blood Glucose Devices market as the pandemic was noted to have disrupted the healthcare system worldwide, causing significant delays in surgeries, treatment, and diagnosis of non-emergency disease conditions. With the increasing number of COVID-19 cases, several local and national regulatory bodies-imposed lockdowns, restricting the movement of people and goods. The pandemic has positively impacted the self-monitoring blood glucose devices market due to high requirement of home care. Furthermore, incidence of COVID-19 has resulted in population shift towards home care. During pandemic, diabetic population were frequently managing blood glucose level to reduce complications and hospitalizations and owing to associated susceptibility to COVID-19.

The COVID-19 pandemic has opened new opportunities for blood glucose monitoring devices and these devices gained more popularity in the diabetic care market. Awareness regarding the benefits of blood glucose monitoring devices increased among the consumers as during the pandemic, there had been an emphasis on the use of virtual clinics and telemedicine for diabetic management. The blood glucose monitoring devices helped patients and healthcare providers improve glycemic control and potentially increase patient self-management, thus changing diabetes care significantly. Further, a surge in the demand for blood glucose monitoring devices due to the quick response by major market players during the Covid-19 pandemic.

Recent Developments
  • In October 2022, Dexcom has begun the global rollout of its G7 continuous glucose monitoring system by making the device available in the U.K., Ireland, Germany, Austria and Hong Kong. The device is designed to be smaller, easier to use and have a better mobile application than its predecessor, while also powering up faster than rival CGM systems. Still the U.S. launch has been delayed, until late 2022.
  • In August 2022, Teladoc Health, the announced the addition of a home A1C testing program to its Livongo by Teladoc Health chronic care solution, making it easier for members to manage and control their diabetes
  • In September 2021, Know Labs Inc, a US-based company that manufactures glucose monitoring devices launched a new portable medical-grade glucose monitoring device named KnowU that utilizes Bio-RFID technology. This device is a non-invasive glucose monitoring machine that has a base that powers the device and displays readings and, a battery a powered monitor with Bio-RFID sensors that can be carried by the users to check sugar levels on the go.
  • In May 2021, Roche collaborated with Eli Lilly and Company, to work towards enhancing the management of insulin pen therapy. With this collaboration, Roche follows its ambition to create an open ecosystem including its own and partner devices, solutions, and services, across the continuum of care in diabetes.
Frequently Asked Questions

Q1. How big is the self-monitoring blood glucose devices market?

Ans. The global self-monitoring blood glucose devices market was valued at USD 18.9 Billion in 2021 and it is anticipated to grow up to USD 45.8 Billion by 2031, at a CAGR of 9.3% during the forecast period.

Q2. What is the self-monitoring blood glucose devices market growth rate?

Ans. The growth rate of the self-monitoring blood glucose devices market is 9.3%

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the self-monitoring blood glucose devices market in 2021.

Q4. Which segment accounted for the largest self-monitoring blood glucose devices market share?

Ans. By distribution channel, the hospital pharmacies segment accounted for the largest Self-Monitoring Blood Glucose Devices market share.

Q5. Who are the key players in the self-monitoring blood glucose devices market?

Ans. The global self-monitoring blood glucose devices market report includes players such as Abbott LaboratoriesBionime CorporationB. Braun Melsungen AGF. Hoffmann-La Roche Ltd.LifeScan IP Holdings, LL, PHC Holdings CorporationTerumo Corporation, Trividia Health, Inc. (Sinocare Inc.)ARKRAY, Inc. and Ypsomed Holding AG., among others.

Q6. What are the factors driving the self-monitoring blood glucose devices market growth?

Ans. The major factors driving the growth of the market are increasing prevalence type 2 diabetes along with rising government initiative to spread awareness regarding diabetes.

Q7. What are the key growth strategies of self-monitoring blood glucose devices market market players?

Ans. The key growth strategies of Self self-monitoring blood glucose devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the self-monitoring blood glucose devices market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the self-monitoring blood glucose devices market during the forecast period.

Read More
Single User License

Wearable Cardiac Devices Market
November, 2022

The global Wearable Cardiac Devices market was valued at USD 1.8 Billion in 2021 and it is anticipated to grow up to USD 9.6 Billion by 2031, at a CAGR of 18.2% during the forecast period.

Wearable cardiac devices are small, portable machines that are worn on the body to monitor heart function. These devices can be used to track heart rate, rhythm, and blood pressure. They can also be used to provide information on heart health and to aid in the diagnosis and treatment of heart conditions.

Global Wearable Cardiac Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$1.8 bn
Market Size in 2031$9.6 bn
Growth Rate (2021-31)18.2%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Application, and Region
Key CompaniesZOLL Medical Corporation, Cardiac Rhythm, iRhtythm Technologies Inc., Proteus Digital Health, Custo Med GmbH, Nuubo, Philips, Welch Allyn, VitalConnect, and Qardio.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Increasing awareness about wearables coupled with preference for homecare devices will augment the market growth. Booming geriatric population base, that is prone to several chronic diseases across the globe will increase the patient pool suffering from cardiac arrhythmias and other CVDs. This will spur the demand for wearable cardiac devices among elderly population. Increasing number of patients suffering from various cardiovascular disorders (CVDs) will primarily drive the market expansion. Wearable cardiac devices such as patches, Holter monitors and wearable ECG devices, assist healthcare professionals and patients in monitoring cardiac parameters. As per the World Health Organization, about 17.9 million people die from CVDs each year. Owing to increased adoption of sedentary and unhealthy lifestyle habits such as excessive consumption of alcohol and smoking, the cases of cardiovascular disorders are increasing at rapid rate.

Market Restraints and Challenges

One of the key restraints in the wearable cardiac devices market is the limited number of indications that are currently approved for these devices. In addition, another key challenge facing the wearable cardiac devices market is the need for long-term data to support the efficacy and safety of these devices.

Global Wearable Cardiac Devices Market Segmental Overview

The report analyses the global Wearable Cardiac Devices market based on product, application, and region

Global Wearable Cardiac Devices Market by Product

Based on product, the market is segmented as Holter monitors, Patch, Defibrillator, and Others. Defibrillators segment in the wearable cardiac devices market is projected to witness significant growth rate through 2031 Wearable defibrillators provide outpatient heart health management, thereby reducing the risk of ventricular tachycardia (VT) and ventricular fibrillation (VF). Further, introduction of wearable technology in defibrillators has increased its application, thereby increasing its acceptance rate.

Global Wearable Cardiac Devices Market by Application

Based on application, the market is segmented as home healthcare, remote patient monitoring, and others. The home healthcare segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2031. This large market revenue is primarily due to the rising geriatric population base suffering with cardiovascular disorders. Moreover, wearable trackers providing efficient monitoring of heart rate and allows access to real time data that helps in identifying risks and reduces hospital visits. Therefore, continuous monitoring of cardiac conditions at home through wearable devices will lead to reduced visits to hospitals, thereby increasing its usage during the forecast period.

Geographical Analysis of Global Wearable Cardiac Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America held significant market share in 2021. This is due to the increasing number of research studies and technological advancement of wearable cardiac devices. Additionally, rising prevalence of cardiovascular diseases significantly contribute to the adoption of wearable monitors among patients, thereby stimulating its demand in the region. The region is showcasing large number of new entrants manufacturing wearables, especially in the U.S. Some of the emerging firms include Qardio, VitalConnect, Proteus Digital Health, Cardiomo and Hemodynamics Company LLC among several others. Furthermore, growing usage of remote monitoring devices will propel the regional revenue in the coming years.

Major Players in the Global Wearable Cardiac Devices Market

The key players in the market ZOLL Medical CorporationCardiac RhythmiRhtythm Technologies Inc.Proteus Digital Health, Custo Med GmbH, NuuboPhilipsWelch AllynVitalConnect, and Qardio. among others.

COVID-19 Impact

The outbreak of COVID-19 has positively impacted wearable cardiac devices credited to growing awareness and acceptance of digital and remote health technology. Applications developed by integrating artificial intelligence (AI) assist medical professionals for continuous monitoring of the patients. Wearables were vastly used to track and monitor cardiac activities during pandemic. These products aid healthcare professionals and in medical trials to monitor patients effectively. Several healthcare companies are working together on various projects for manufacturing of Holter monitors, smartwatches and patches among others to provide medical aid. Also, with significant rise in COVID-19 cases, scientists and manufacturers collaborated to pool their resources to detect and treat COVID-19 more effectively, thereby meeting contactless necessities.

Recent Developments
  • In October 2021, Mobvoi and CardieX announced about its plan to launch a novel smartwatch with exclusive cardiac-health benefits SphygmoCor technology in Australia and the U.S. The proprietary technology-based product will offer competitive advantage and customer base to the firm.
  • in June 2021, LifeQ, world’s highly-dominant provider of biometric and health information derived from wearable devices, announced its partnership with CONNEQT, a consumer health organization that provides wearables and other consumer health apps, to enable the CONNEQT Band that consists of an additional fingertip sensor. The partnership also aimed to further boost the latters heart-health-centric offerings and strengthen its footprint in the competitive market
  • In November 2020, Royal Philips and African Union announced a partnership to strengthen healthcare infrastructure and enhance access to care in African Union Member States by improving access to medical equipment.
  • In February 2020, Centers for Disease Control and Prevention discovered a potential solution to track cardiovascular health population trends with the help of consumer wearable.
Frequently Asked Questions

Q1. How big is the wearable cardiac devices market?

Ans. The global wearable cardiac devices market was valued at USD 1.8 Billion in 2021 and it is anticipated to grow up to USD 9.6 Billion by 2031, at a CAGR of 18.2% during the forecast period.

Q2. What is the wearable cardiac devices market growth rate?

Ans. The growth rate of the wearable cardiac devices market is 18.2%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the wearable cardiac devices market in 2021.

Q4. Which segment accounted for the largest wearable cardiac devices market share?

Ans. By application the home healthcare segment accounted for the largest wearable cardiac devices market share.

Q5. Who are the key players in the wearable cardiac devices market?

Ans. The global wearable cardiac devices market report includes players such as  ZOLL Medical CorporationCardiac RhythmiRhtythm Technologies Inc.Proteus Digital Health, Custo Med GmbH, NuuboPhilipsWelch AllynVitalConnect, and Qardio. among others.

Q6. What are the factors driving the wearable cardiac devices market growth?

Ans. The major factors driving the growth of the market are rising prevalence of cardiac disorders across the globe.

Q7. What are the key growth strategies of wearable cardiac devices market players?

Ans. The key growth strategies of wearable cardiac devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the wearable cardiac devices market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the wearable cardiac devices market during the forecast period.

Read More
Single User License

Wound Dressing Market
November, 2022

The Wound Dressings market was valued at USD 17.5 billion in 2021 and it is anticipated to grow further till USD 31.8 billion by 2031, at a CAGR of 6.2% during the forecast period.

According to British Diabetic Association, diabetic individuals have a 30x greater risk of getting an amputation than the general population. Due to the high likelihood, many amputation surgeries are performed each year, necessitating effective wound dressing to stop infections after surgery. Active, passive, and interactive dressings are the three categories into which wound dressings are divided. Products for wound dressings that are passive serve solely a protective purpose, whereas active wound dressings encourage healing by maintaining a moist wound environment. As a result, it is anticipated that demand for cutting-edge wound dressings made of hydrogels and foams will rise.

Global Wound Dressings Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 17.5 Billion
Market Size in 2031US$ 31.8 Billion
CAGR %6.2%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredType, Application, End User, and Region
Key Companies3M; Coloplast Corp.; Medline Industries; Smith & Nephew; Medtronic; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Ethicon (Johnson & Johnson); Baxter International; and Molnlycke Health Care AB among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The market is anticipated to expand as a result of an increase in traumatic accidents around the world, an increase in the geriatric population, and the incidence rate of various wounds such as pressure ulcers and surgical site wounds. Globally, the number of chronic lesions such diabetic foot ulcers and venous leg ulcers is rising. For instance, the NCBI estimates that approximately 6.5 million Americans suffer from various types of chronic wounds.

Market Restraints and Challenges

Chronic wounds, such as leg ulcers, pressure sores, and diabetic foot ulcers, can become more serious as a result of delayed diagnosis and treatment, necessitating foot amputations. In contrast to Western countries, the rate of delayed diagnosis is significantly higher in rising nations like Brazil, China, and India. This is brought on by a lack of set regulations and action plans by governing authorities, a lack of access to well-developed healthcare infrastructure, and a lack of awareness among communities about difficult-to-heal wounds.

Global Wound Dressings Market Segmental Overview

The report analyses the global Wound Dressings market based on the type, application, end user, and region.

Global Wound Dressings Market by Type

Based on the type, it is segmented into advanced wound dressing, traditional Wound Care products, negative pressure wound therapy, bioactive, and others. The advanced wound dressing segment is anticipated to dominate the market during the forecast period. The high growth of the segment is primarily attributed to the higher demand and adoption of foam dressings, antimicrobial dressings and alginate dressings.

Global Wound Dressings Market by Application

Based on the application, it is segmented into chronic wounds, and acute wounds. The chronic wounds segment is anticipated to dominate the market during the forecast period. The dominance is primarily attributed to the increasing patient population suffering from diabetic foot ulcers and pressure ulcers, coupled with the increasing expenditure on treating these conditions.

Global Wound Dressings Market by End User

Based on the end user, it is segmented into hospitals, clinics, home care settings, and others. The hospital segment is anticipated to dominate the market during the forecast period. The growth of the segment is primarily attributed to the increase in the number of multispecialty hospitals with departments dedicated to wound management, majorly in emerging countries.

Geographical Analysis of the Global Wound Dressings Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. The strong presence of key players in the region, large patient population suffering from chronic and acute wounds, and higher per capita healthcare expenditure are some of the major factors boosting the growth of the market.

Major Players in the Global Wound Dressings Market

The major players analyzed in the report are 3M; Coloplast Corp.; Medline Industries; Smith & Nephew; Medtronic; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Ethicon (Johnson & Johnson); Baxter International; and Molnlycke Health Care AB among others.

COVID-19 Impact

The COVID-19 outbreak has had a detrimental effect on the market. In 2020, few market participants reported revenue losses as a result of the pandemic. Additionally, in the early half of the year, the governments of major nations redistributed beds, nurses, and other critical staff to clinics in order to treat COVID-19 patients. As a result, wound management was removed from the list of essential procedures. The revenue generated in 2020 was significantly down for several market participants. For instance, the advanced wound management business of Smith & Nephew plc had a 5.1% decline. Additionally, ConvaTec Inc. saw a 4.1% drop in revenue from its advanced Wound Dressings segment in 2020 compared to 2019.

Recent Developments
  • November 2021, ConvaTec Group PLC extended its partnership with Vizient, Inc., for advanced Wound Dressings products, technologies and services for a further three years up to 2025.
  • June 2020, Molnlycke Health Care AB announced the launch of new Wound Dressings patient educational resources to support patients and healthcare professionals during the coronavirus pandemic.
  • January 2020, ConvaTec announced the launch of ConvaMax, which helps in managing highly excluding wounds, including leg ulcers, surgical wounds, and diabetic foot ulcers.
  • September 2018, ConvaTec received the US FDA 510(k) clearance for its AQUACEL Ag advantage antimicrobial dressings.
  • November 2018, Molnlycke introduced the Mepilex Border Flex dressing engineered to support fewer dressing changes and reduce dressing costs and waste while creating an optimal healing environment.
Frequently Asked Questions

Q1. How big is the Wound Dressings market?

Ans. The global Wound Dressings market size was USD 17.5 billion in 2021 and it is anticipated to grow further till USD 31.8 billion by 2031, at a CAGR of 6.2% from 2022 to 2031.

Q2. What is the Wound Dressings market growth rate?

Ans. The growth rate of the Wound Dressings market is 6.2%.

Q3. Which region holds a major market share for the Wound Dressings market?

Ans. North America holds a major market share of the Wound Dressings market in 2021.

Q4. Which segment accounted for the largest Wound Dressings market share?

Ans. By end user, the hospitals segment accounted for the largest Wound Dressings market share.

Q5. Who are the key players in the Wound Dressings market?

Ans. The global Wound Dressings market report includes players such as 3M; Coloplast Corp.; Medline Industries; Smith & Nephew; Medtronic; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Ethicon (Johnson & Johnson); Baxter International; and Molnlycke Health Care AB among others.

Q6. What are the factors driving the Wound Dressings market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Wound Dressings market players?

Ans. The key growth strategies of Wound Dressings market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Wound Dressings market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Wound Dressings market during the forecast period.

Read More
Single User License

Acute Myeloid Leukemia (AML) – Drug Pipeline Landscape, 2022
November, 2022

Leukemia is a malignant disease of the blood cells. The four main types of leukemia are acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). AML is the most common type of leukemia in adults, accounting for about 80% of all cases.

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) is a type of blood cancer in which the bone marrow produces a large number of abnormal blood cells which is also called as Acute Myeloid Leukemia, Acute Granulocytic Leukemia and Acute Nonlymphocytic Leukemia.

The most common causes of Acute Myelocytic Leukemia are mutations in the DNA, smoking, previous chemotherapy treatment, exposure to radiation, hazardous chemical exposure, age, other genetic or blood disorders.

The most common symptoms of Acute Myelocytic Leukemia include fever, fatigue, paleness or loss of normal skin colour, unusual bleeding/ bruises, frequent infections, headache, weight loss, shortness of breath etc.

Acute Myelocytic Leukemia can be diagnosed by the doctors by a physical exam to look for signs of bleeding, bruising, or infection. Diagnostic tests include Blood tests, Imaging tests, Bone marrow tests, Spinal tap, Genetic tests etc.

The most common treatments for Acute Myelocytic Leukemia are Chemotherapy, Radiotherapy, Stem cell transplantation, Targeted therapy with either or combinations as Remission induction therapy and Consolidation therapy.

The prognosis for AML varies depending on the age of the patient and the subtype of the disease. In general, the outlook is better for younger patients and those with certain subtypes of AML. With treatment, many people are able to achieve remission, but the disease can recur.

Report Highlights

Global Insight Service’s, Acute Myeloid Leukemia (AML) – Drug Pipeline Landscape, 2022 report provides an overview of the Acute Myeloid Leukemia (AML) pipeline drugs. This report covers detailed insights on Acute Myeloid Leukemia (AML) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Acute Myeloid Leukemia (AML) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Helicobacter Pylori Testing Market
November, 2022

The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Helicobacter pylori testing is a way to determine if a person has an infection with the bacteria Helicobacter pylori. This bacteria is known to cause stomach ulcers, and testing can help to diagnose an infection and determine the best course of treatment. There are a few different ways to test for H. pylori, including a stool sample, a breath test, or a biopsy.

Global Helicobacter Pylori Testing Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$436.0 mn
Market Size in 2031$915.4 mn
Growth Rate (2021-31)7.7 %
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredTest Type, Method, End-user, and Region
Key CompaniesAbbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Medline Industries, Inc. , Thermo Fisher Scientific Inc. and QIAGEN.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The most important driver of the H. pylori testing market is the high prevalence of H. pylori infection. It is estimated that H. pylori infects more than half of the world’s population. The prevalence is highest in developing countries and lowest in developed countries. The second important driver of the H. pylori testing market is the increasing awareness of the link between H. pylori infection and gastric cancer. Gastric cancer is the fourth most common cancer in the world and the second leading cause of cancer death. H. pylori infection is a major risk factor for gastric cancer. The third important driver of the H. pylori testing market is the increasing incidence of ulcers. Ulcers are a common condition and their incidence is increasing due to the increasing prevalence of H. pylori infection. The fourth important driver of the H. pylori testing market is the increasing demand for rapid and accurate testing methods. The currently available methods for H. pylori testing are culture, histology, urea breath test, and stool antigen test. However, these methods are time-consuming and expensive. The fifth important driver of the H. pylori testing market is the development of new and improved testing methods. Newer methods, such as PCR and ELISA, are more rapid and accurate than the older methods.

Market Restraints and Challenges

Helicobacter pylori infection is typically diagnosed through an invasive procedure, which entails biopsy and endoscopy, and requires advanced operational skills for precisely diagnosing and identifying the appropriate treatment method. However, the lack of trained professionals in nations with limited healthcare resources may affect the disease testing rates, dampening the market progress. Many low and middle-income economies lack the hospital and medical training infrastructure needed to highly skilled physicians. Helicobacter pylori treatment also poses other challenges for physicians as no first-line therapy can treat the infection for all patients.

Global Helicobacter Pylori Testing Market Segmental Overview

The report analyses the global Helicobacter Pylori Testing Market based on test type, method, end-user, and region.

Global Helicobacter Pylori Testing Market by Test Type

Based on test type, the market is segregated as Invasive, and Non-invasive. Amongst them, invasive helicobacter test segment is poised to register a significant CAGR from 2023 to 2031, driven by the efficacy and cost-effectiveness of rapid urease tests. The demand for invasive testing method is also high among patients do not correspond well to antibiotic therapy, have symptoms of severe gastric problems, and further require gastric endoscopy.

Global Helicobacter Pylori Testing Market by Method

On the basis of the method, the helicobacter pylori testing market is categorized into laboratory-based tests and point-of-care (POC) tests. The POC tests segment accounted for a significant business share in 2022, due to its non-invasive nature and its ability to deliver fast results. This is also attributed to collaborative research initiatives by leading industry giants and increasing R&D spending, which is further encouraging technological advancements as well as new product launches.

Global Helicobacter Pylori Testing Market by End-user

With regards to end-user, the Helicobacter Pylori Testing Market is divided into Hospital & Clinics, Diagnostic labs, and others. Hospital & Clinics generated considerable revenue in 2021 and is expected to grow at a highest CAGR over the analysis period. This is owing to the rising patient preference for clinics due to affordability and quality care. This is driven by the high-quality treatment and quick assistance offered by clinics, which provides the desired treatment results at a reasonable cost. In addition, the high-end services offered by clinics through effective disease management strategies are further set to spur segment expansion.

Geographical Analysis of Global Helicobacter Pylori Testing Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Helicobacter Pylori Testing Market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the presence of industry leaders, as well as an emphasis on continual technological developments and new product releases, has contributed to the regional market’s growth. Revenue growth is slated to be fueled by the rising occurrences of infectious ailments and increasing aging population in the region. Poor healthcare infrastructure and low awareness about good sanitary practices across developing APAC economies is further projected to fuel the demand for helicobacter pylori tests.

Major Players in the Global Helicobacter Pylori Testing Market

The key players in the Helicobacter Pylori Testing Market Abbott LaboratoriesAvanos CorporateBiohit OyjBio-Rad Laboratories, Inc.Cardinal HealthExalenz Bioscience Ltd.Gulf Coast ScientificMedline Industries, Inc. Thermo Fisher Scientific Inc. and QIAGEN. among others.

COVID-19 Impact

In the initial months of 2020, COVID-19 made a severe negative impact on the h. pylori testing industry. Many h. pylori patients avoided hospital visits on account of the rapidly increasing COVID-19 cases and mortality rates, which overwhelmed healthcare facilities and spread infection fears among the global population. Additionally, the infection risks associated with invasive helicobacter pylori testing at point-of-care treatment units also led to disruption in the sector. Since the route of virus transmission is nasal or oral, the non-invasive tests such as the urea breath tests (UBT) were also impacted as they held a high possibility of COVID-19 transmission. Now, as successful vaccination drives turn COVID-19 into an afterthought, the market is expected to bounce back in a notable manner.

Recent Developments
  • In June 2022, Phathom Pharmaceuticals announced that FDA approved Voquenza (vonoprazan fumarate), in combination with anti-biotics, for H.pylori infection.
  • In September 2021, Phathom Pharmaceuticals Submited two NDAs to U.S. FDA for Vonoprazan-based treatment regimens for the treatment of H. pylori infection.
  • In July 2021, Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
  • In March 2020, RedHill Biopharma Ltd., announced the U.S. commercial launch of Talicia® 1 delayed-release capsules 10 mg2/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults. RedHills expanded U.S. sales force will promote Talicia® nationwide to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers.
Frequently Asked Questions

Q1. How big is the Helicobacter Pylori Testing Market ?

Ans. The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Q2. What is the Helicobacter Pylori Testing Market growth rate?

Ans. The growth rate of the Helicobacter Pylori Testing Market is 17.1%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Helicobacter Pylori Testing Market in 2021.

Q4. Which segment accounted for the largest Helicobacter Pylori Testing Market share?

Ans. By end user, the hospital& clinics segment accounted for the largest Helicobacter Pylori Testing Market share.

Q5. Who are the key players in the digital diabetes management market?

Ans. The global Helicobacter Pylori Testing Market report includes players such as  Abbott LaboratoriesAvanos CorporateBiohit OyjBio-Rad Laboratories, Inc.Cardinal HealthExalenz Bioscience Ltd.Gulf Coast ScientificMedline Industries, Inc. Thermo Fisher Scientific Inc. and QIAGEN, among others.

Q6. What are the factors driving the Helicobacter Pylori Testing Market growth?

Ans. The major factors driving the growth of the market are growing prevalence of H, pylori across the globe.

Q7. What are the key growth strategies of Helicobacter Pylori Testing Market players?

Ans. The key growth strategies of Helicobacter Pylori Testing Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period.

Read More
Single User License

Blockchain Technology in Healthcare Market
November, 2022

The global Blockchain Technology in Healthcare Market was valued at USD 1.5 Billion in 2021 and it is anticipated to grow up to USD 16.2 Billion by 2031, at a CAGR of 27.3% during the forecast period.

Blockchain technology is a distributed database that allows for secure, transparent and tamper-proof sharing of data. In healthcare, blockchain can be used to create a secure and interoperable system for storing and sharing medical data. By creating a decentralized network of health data, blockchain can help to reduce errors, improve data quality and increase trust between patients and providers. Additionally, blockchain can help to enable new applications such as clinical trial management, drug supply chain tracking and patient-centered data sharing.

Global Blockchain Technology in Healthcare Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$1.5 bn
Market Size in 2031$16.2 bn
Growth Rate (2021-31)27.3%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredTest, Application, End-user, and Region
Key CompaniesAkiri, Inc., Avaneer Health, Inc., BurstIQ, Crystalchain, Change Healthcare, Inc., Chronicled, Equideum Health, Embleema, Farma Trust, and Guardtime.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Growing need to store & secure medical data coupled with the rising incidence of medical data breaches to spur the blockchain technology in healthcare market expansion

There has been a surge in the requirement to store and secure medical data that can have significant advantages for healthcare facilities, medical staff, and patients. Blockchain technology is cross-checked, encrypted, and decentralized that enables medical data to remain strongly backed, thereby providing stimulus to the market progression. The government of several countries is emphasizing on the digitalization of the healthcare system and related industry sectors that potentially improve health outcomes, enhance patient engagement, enable better predictions, etc. Owing to increased attack volume for various healthcare service providers, the U.S. and UK government has made a significant investment to ensure that all health records are digitized. Further, medical data has been subjected to risks of privacy breaches attributed to unauthorised access to electronic health records (EHR) or loss of physical patient files.

Market Restraints and Challenges

Lack of skilled professionals with the required technical expertise to handle blockchain technology in healthcare may have a negative impact on the market growth. Blockchain technology in healthcare is complex in nature and henceforth, requires skilled professionals to operate and manage the task. Lack of a skilled workforce, particularly in the emerging economies may hamper the adoption of blockchain technology in healthcare. Apart from the revenue loss, the shortage of skilled professionals in handling this technology also produces a variety of other negative consequences for firms such as the inability to deliver precise market needs, affecting customer satisfaction, etc.

Global Blockchain Technology in Healthcare Market Segmental Overview

The report analyses the global Blockchain Technology in Healthcare Market based on type, application, end-user, and region.

Global Blockchain Technology in Healthcare Market by Type

Based on type, the market is segregated as private, and public. Amongst them, public segment is poised to register a significant CAGR from 2023 to 2031 led by the rising preference for a public blockchain system that provides several advantages comprising greater transparency, offer decentralized structure, and records everything among others. This blockchain system is widely used to manage healthcare data efficiently. Digital ledger technology (DLT) and Ethereum, a public network, are one of the broadly used blockchain systems in healthcare. The digital ledger technology is highly secure, eliminates the need for a third-party caretaker, and delivers a high amount of transparency. Public blockchain technology is specifically designed to operate with maximum medical data security, thereby augmenting the industry value. Further, the cost-effectiveness of implementing public blockchain technology in healthcare is the key factor that leads to industry expansion. Featuring a high standard of security protocols, reliable portal services, and anonymous nature are expected to positively influence the market demand.

Global Blockchain Technology in Healthcare Market by Application

On the basis of application, the Blockchain Technology in Healthcare Market is categorized into Clinical Trials, Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing Management, and Others. The clinical trials segment held significant share of the blockchain technology in healthcare market in 2021 impelled by the wide range applications of blockchain technology for improving clinical trials quality. Implementation of this technology enhances recruitment, allows full decentralization, supports governance with real-time decision making, and optimizes the performance of repetitive tasks that enable trials to take place effectively. Blockchain technology aids in reaching a considerable level of historicity and inviolability of data for the whole document flow in a clinical trial. This further allows the secure automation of clinical trials through smart contracts, ensures traceability, and prevents a posteriori reconstruction.

Global Blockchain Technology in Healthcare Market by End-user

With regards to end-user, the Blockchain Technology in Healthcare Market is divided into Pharmaceutical Companies, Healthcare Payers, Healthcare Providers, and Others. The healthcare providers segment captured significant revenue in 2021 driven by the broad range of uses and applications of blockchain technology in healthcare. The digital ledger technology supports healthcare providers through managing the medicine supply chain efficiently and facilitating the secure transfer of patient medical records. This technology has increased the productivity of healthcare providers by offering a novel model for health information exchanges by making electronic medical records more resourceful. The blockchain system is providing opportunities to healthcare providers by reducing or eliminating the friction and costs of current intermediaries. Additionally, it reduces complexity and creates secure & immutable information.

Geographical Analysis of Global Blockchain Technology in Healthcare Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Blockchain Technology in Healthcare Market revenue is poised to grow significant CAGR during the forthcoming years. The major market share is attributable to the recent advancements in blockchain technology along with several government initiatives supporting the acceptance of these innovative platforms in healthcare. Venture capital investors are identifying the enormous potential that blockchain technology can offer for enhancing patient care, broadening the reach of health services, and cutting down medical care expenses. Companies functioning in the country comprising BurstIQ, Akiri, Factom, etc. are emphasizing on the development of blockchain technology solutions that ensures healthcare data to remain secured, provide complete and up-to-date information about patients’ health & healthcare activity, etc. Similarly, robust economic growth in the U.S. has led market to showcase strong growth in value terms.

Major Players in the Global Blockchain Technology in Healthcare Market

The key players in the Blockchain Technology in Healthcare Market Akiri, Inc., Avaneer Health, Inc.BurstIQCrystalchainChange Healthcare, Inc.ChronicledEquideum Health, EmbleemaFarma Trust, and Guardtime, among others.

COVID-19 Impact

The COVID-19 pandemic arose as an unparalleled health concern, infecting a significant number of people across the world. The pandemic inflicted economic damages and financial adversities on global economy and several industrial sectors. Several countries imposed national emergencies and lockdowns to curb the spread & infection due to the SARS-CoV-2. Clinical studies and surveys have reported a drop in the outpatient and emergency medical services in the U.S. Many medical practices were hampered, distracted, postponed and halted, especially the elective medical practices, thereby impacting the industry growth.

However, the coronavirus outbreak propelled the acceptance of innovative technologies comprising blockchain technology in healthcare. Several countries implemented blockchain technology in healthcare facilities that aided in effective planning operations and resource deployments. This technology has enhanced clinical trial data management by reducing delays in regulatory approvals, streamlined the communication between diverse stakeholders of the supply chain, etc. Furthermore, numerous market players are focused to develop a blockchain-based tracking system to halt the spread of misinformation.

Recent Developments
  • In Aug-2022, Oracle teamed up with InfStones, the world’s leading blockchain infrastructure provider. This collaboration aimed at combining InfStones’ top blockchain development platform with Oracle Cloud Infrastructure (OCI) to boost Web3 development. This collaboration would assist in delivering major insights that drive the development, evolution, and adoption of Web3 applications across the globe.
  • In Jul-2022, Equideum Health entered into a partnership with SIMBA Chain, a cloud-based, blockchain-as-a-service (BaaS) platform. This partnership aimed to enhance global healthcare by developing a decentralized marketplace called the Equideum Exchange to empower individuals to monetize health as well as health-associated data about them.
  • In May-2022, Equideum Health teamed up with Nokia Bell Labs, an American industrial research and scientific development company. This collaboration aimed to use data generated from video feeds, wearables, smartphones, and home health devices.
  • In Apr-2022, Chronicled partnered with AmerisourceBergen, an American drug wholesale company. This partnership aimed to use a new blockchain-powered solution developed to improve pharmaceutical chargeback accuracy and substantially decrease chargeback rejections.
  • In Aug-2021, Chronicled came into a partnership with MediLedger, an industry-owned permissioned blockchain network. This partnership aimed to use the latest blockchain-powered solution on the MediLedger Network to simplify operations over the pharmaceutical supply chain and allow a reliable, frictionless experience for pharmacies over the country.
  • In May-2021, BurstIQ entered into collaboration with The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). This collaboration aimed to acknowledge the protection of intellectual property related to NCATS’ work on translational science.
  • In Jun-2020, Oracle came into a collaboration with HACERA, a US-based technology company. This collaboration aimed to provide reliable information through MiPasa platform.
Frequently Asked Questions

Q1. How big is the Blockchain Technology in Healthcare Market?

Ans. The global Blockchain Technology in Healthcare Market was valued at USD 1.5 Billion in 2021 and it is anticipated to grow up to USD 16.2 Billion by 2031, at a CAGR of 27.3% during the forecast period.

Q2. What is the Blockchain Technology in Healthcare Market growth rate?

Ans. The growth rate of the Blockchain Technology in Healthcare Market is 27.3%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Blockchain Technology in Healthcare Market in 2021.

Q4. Which segment accounted for the largest Blockchain Technology in Healthcare Market share?

Ans. By end user, the Healthcare Providers segment accounted for the largest Blockchain Technology in Healthcare Market share.

Q5. Who are the key players in the digital diabetes management market?

Ans. The global Blockchain Technology in Healthcare Market report includes players such  as Akiri, Inc., Avaneer Health, Inc.BurstIQCrystalchainChange Healthcare, Inc.ChronicledEquideum Health, EmbleemaFarma Trust, and Guardtime, among others.

Q6. What are the factors driving the Blockchain Technology in Healthcare Market growth?

Ans. The major factors driving the growth of the market are growing prevalence of H, pylori across the globe.

Q7. What are the key growth strategies of Blockchain Technology in Healthcare Market players?

Ans. The key growth strategies of Blockchain Technology in Healthcare Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Blockchain Technology in Healthcare Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Blockchain Technology in Healthcare Market during the forecast period.

Read More
Single User License

Diabetic Gastroparesis – Drug Pipeline Landscape, 2022
November, 2022

Diabetic Gastroparesis is a serious complication of diabetes resulting in delayed gastric emptying with associated upper gastrointestinal (GI) symptoms in the absence of any mechanical obstruction. Gastroparesis is a digestive disorder with a high incidence among people with long-standing diabetes.

Gastroparesis can cause due to the damage of vagus nerve. Certain medications, such as opioid pain relievers, some antidepressants, and high blood pressure and allergy medications, can lead to slow gastric emptying and cause similar symptoms.

Symptoms of diabetic gastroparesis includes nausea, vomiting and abdominal pain. It can also cause problems with blood sugar levels and nutrition, feeling of fullness after eating just a few bites, vomiting undigested food eaten a few hours earlier, acid reflux, changes in blood sugar levels, lack of appetite, weight loss and malnutrition.

Doctors most often diagnose diabetic gastroparesis by using the tests such as scintigraphy, breath tests, upper gastrointestinal (GI) endoscopy, wireless motility capsule, barium X-ray, gastric manometry, radioisotope gastric-emptying scan.

The most common investigative treatments include metoclopramide (Reglan) and erythromycin. Surgery in some cases may improve outcomes. Symptoms can be eased through lifestyle changes and home remedies like eating smaller meals more frequently, avoid fibrous fruits and vegetables, drink about 34 to 51 ounces (1 to 1.5 liters) of water a day.

Report Highlights

Global Insight Service’s, Diabetic Gastroparesis – Drug Pipeline Landscape, 2022 report provides an overview of the Diabetic Gastroparesis pipeline drugs. This report covers detailed insights on Diabetic Gastroparesis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Diabetic Gastroparesis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Aquaculture Vaccines Market
November, 2022

The global Aquaculture Vaccine Market was valued at USD 201.5 million in 2021 and it is anticipated to grow up to USD 320.3 million by 2031, at a CAGR of 4.7% during the forecast period.

Aquaculture vaccines are vaccines that are used to protect fish, shellfish, and other aquatic animals from disease. Aquaculture is the farming of aquatic animals, and it is a growing industry worldwide. Aquaculture vaccines are used to prevent diseases that can decimate entire stocks of fish or shellfish, and they are an important tool for protecting the health of these animals. Aquaculture vaccines are typically administered via injection or immersion. Injection is the most common method of vaccination, and it is typically done with a needle and syringe. Immersion is a less common method, and it involves placing the fish or shellfish in a tank of water that contains the vaccine. Aquaculture vaccines are typically made from inactivated or attenuated (weakened) viruses, bacteria, or other pathogens.

Global Aquaculture Vaccine Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$201.5 mn
Market Size in 2031$320.3 mn
Growth Rate (2021-31)4.7%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredType of Vaccine, Species, Infections, Route of Administration, Distribution Channel, Region
Key CompaniesZoetis, Phibro Animal Health Corporation, Elanco, Merck & Co., Inc., KBNP, CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, and HIPRA
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Vaccination of farmed fish has significant benefits in combating viral and bacterial diseases with absence of undesirable side-effects of antibiotics. Also, overuse of antibiotics leads to development of resistance that ultimately leads to loss of aquaculture produce and significant economic losses. Currently, countries in Europe such as Norway have virtually stopped use of antibiotics in aquaculture practices. This has positively influenced the aquaculture vaccines market growth and lowering the risk of antibiotic resistance. Moreover, with introduction of DNA and subunit vaccines due to technological advancements, the adoption of aquaculture vaccines will increase as compared to antibiotics.

Market Restraints and Challenges

Stringent regulatory policies for manufacturing and approval of aquaculture vaccines is one of the major growth impending factors. Majority of countries have their own regulatory processes and agencies for aquaculture vaccine products approval. Also, multiple approvals are required for commercialization of aquaculture vaccines. However, long and tedious approval process by the U.S. FDA and European Union will act as the major entry barrier for new vaccines and put additional restrain on current market players.

Global Aquaculture Vaccine Market Segmental Overview

The report analyses the global Aquaculture Vaccine Market based on Type of Vaccine, Species, Infections, Route of Administration, Distribution Channel, and Region

Global Aquaculture Vaccine Market by Type of Vaccine

Based on the product type, the Aquaculture Healthcare industry is bifurcated into inactivated vaccines, live vaccines, and others. Of these, the inactivated vaccines segment registered significant revenue in 2021. The inactivated vaccines produce strong immune responses by retaining inactivated genomic component and the virus surface exposed antigens are important for strong immune response. Moreover, inactivated vaccine does not persist in the vaccinated fish or within the environment, thus they are safe in nature, thereby fostering the demand.

Global Aquaculture Vaccine Market by Species

Based on species, market is segmented into salmon, trout, tilapia, and others. The salmon segment dominated overall market share in 2021. Factors such as growing demand for salmon products along with increasing need for protection against viral and bacterial infections will augment the aquaculture vaccines market growth for salmons. Also, ban on sales of antibiotics for aquaculture will positively drive demand. Additionally, growing demand for fish protein will add more pressure on the wild fish reserve, thus leading to business expansion. Various technological advances and innovations will lead to high adoption rate of salmon vaccines.

Global Aquaculture Vaccine Market by Application

Based on applications, the Aquaculture Healthcare industry is categorized bacterial infection, viral infection, and others. The segment bacterial infection accounted for lucrative market share in 2021. Factor such as increasing incidence of bacterial infections such as vibriosis, streptococcosis, pseudomonasis and others in various fish species. Growing prevalence of bacterial infections in aquaculture has claimed millions of fish lives, this resulted in the heavy economic losses for fish farmers as well as regional economy.

Global Aquaculture Vaccine Market by Route of Adminstration

Based on the route of administration, the industry is categorized into inactivated vaccine, live vaccine, and others. The inactivated vaccine segment accounted significant revenue share in 2021. The inactivated vaccines produce strong immune responses by retaining inactivated genomic component and the virus surface exposed antigens are important for strong immune response. Moreover, inactivated vaccine does not persist in the vaccinated fish or within the environment, thus they are safe in nature, thereby fostering the demand.

Geographical Analysis of Global Aquaculture Vaccine Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Aquaculture Vaccine Market captured significant market share in 2021 and is poised to grow substantially during the forthcoming years. Increasing research and development investment by major players such as Zoetis Inc. and Merck & Co. is fuelling the regional industry revenue. Also, government funding for development of aquaculture vaccines will further escalate the market share. For instance, in February 2021, the Foundation for Food & Agriculture Research (FFAR) funded about USD 790,326 for seeding solutions grant to the University of Florida. This fund aimed to help develop a vaccine delivery system that will prevent the spread of tilapia lake virus and other diseases in the aquaculture industry.

Major Players in the Global Aquaculture Vaccine Market

The key players in the market ZoetisPhibro Animal Health CorporationElancoMerck & Co., Inc.KBNPCAVACKyoto Biken Laboratories, Inc.Nisseiken Co., Ltd.Vaxxinova International BV, and HIPRA. among others.

COVID-19 Impact

The spread of COVID-19 pandemic across the globe has impacted the aquaculture vaccine in industry negatively in 2020. This is attributed to increasing number of COVID-19 infections along with logistical disruption in supply chains. Furthermore, decrease in the production of aquaculture vaccines owing to the reduced workforce coupled with shifting trends to develop vaccine for COVID-19 infection has influence the market growth negatively in 2020 to certain extent. However, with consecutive second and third wave of COVID-19 infections in various countries, the market is set to observe a sluggish growth in the short-term period.

Recent Developments
  • In October 2022, Hyderabad-based Indian Immunologicals (IIL), a subsidiary of National Dairy Development Board (NDDB), has forayed into the aquaculture health segment with the launch of its products to serve the growing need in farmed shrimp and fish in the country.
  • In April 2021, ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.
  • In September 2020, Virbac announced the acquisition of range of tilapia vaccines from Ictyogroup, an animal health company specialized in R&D biology. In addition to this acquisition, the two companies signed a partnership agreement for the development of new vaccines and new formulations for the Aqua Virbac division. This agreement is expected to avail the complete and innovative range of tilapia vaccines in Africa, Asia and Latin America. This strategy enabled company to add value to its existing portfolio and expand their customer base in untapped economies.
  • In January 2020, Barramundi Asia, a Singapore based company announced a merger with compatriot Allergo Aqua. The merger aimed to bring in-house fingerling R&D vaccination. This strategy helped companies to maintain long-term business relations, thereby strengthening its market presence.
Aquaculture Vaccine Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Aquaculture Vaccine Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Aquaculture Vaccine Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Aquaculture Vaccine Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the Aquaculture Vaccine Market?

Ans. The global Aquaculture Vaccine Market size was USD 201.5 million in 2021 and is anticipated to reach USD 320.3 million in 2031, growing at a rate of 4.7% from 2022 to 2031.

Q2. What is the Aquaculture Vaccine Market growth rate?

Ans. The growth rate of the Aquaculture Vaccine Market is 4.7%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Aquaculture Vaccine Market in 2021.

Q4. Which segment accounted for the largest Aquaculture Vaccine Market share?

Ans. By route of administration,, the oral vaccine segment accounted for the largest Aquaculture Vaccine Market share.

Q5. Who are the key players in the Aquaculture Healthcare Market?

Ans. The global Aquaculture Vaccine Market report includes players such  ZoetisPhibro Animal Health CorporationElancoMerck & Co., Inc.KBNPCAVACKyoto Biken Laboratories, Inc.Nisseiken Co., Ltd.Vaxxinova International BV, and HIPRA. among others.

Q6. What are the factors driving the Aquaculture Vaccine Market growth?

Ans. The major factors driving the growth of the market are Growing incidence of diseases and parasites in farmed fish.

Q7. What are the key growth strategies of Aquaculture Vaccine Market players?

Ans. The key growth strategies of Aquaculture Vaccine Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Aquaculture Vaccine Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Aquaculture Vaccine Market during the forecast period.

Read More
Single User License

Drone Sensors Market
November, 2022

The global Drone Sensor Market was valued at USD 568.2 Million in 2021 and it is anticipated to grow up to USD 4,032.8 Million by 2031, at a CAGR of 21.1% during the forecast period.

The drone is a flying robot or aircraft with onboard sensors, a global positioning system, and software that allows it to be remotely controlled or fly on its own. Unmanned Aerial Vehicles (UAVs) and Unmanned Aircraft Systems are other names for drones (UAS). Previously, Unnamed Aerial Vehicles (UAVs) were only employed for military-related tasks like training for air defense target engagements, information gathering, and, more controversially, as a platform for carrying weapons.

Global Drone Sensor Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$568.2 Mn
Market Size in 2031$4,032.8 Mn
Growth Rate (2021-31)11.6%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredSensor Type, Application, Platform Type, End User, And Region
Key CompaniesAinstein (US), Trimble (US), Bosch Sensortec (Germany), TDK InvenSense (Japan), Sparton NavEx (US), , Raytheon (US), ams AG (Austria), Infineon Technologies AG (Germany), PrescisionHawk (US), Sentera, Inc. (US), and SlantRange (US).
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The rising adoption rate of several unmanned flight systems i.e. drones, across the world intended for a wide range of commercial applications, is one of the most significant drivers for the development of the global drone sensor market. The increasing demand for commercial applications, such as shipping, precision agriculture, wildlife monitoring, aerial photography as well as videography, and logistics and delivery, is also motivating the sales within the global drone sensor market. Additionally, the constant technological developments that make the components, hardware, and technologies used in drones are also paving the way for the next generation of ultimate drones. The growing demand for effective, high strength, and advanced drones from industrial sector is also pivotal for the further development of the global drone sensor market in coming few years.

Market Restraints and Challenges

Security concerns about the usage of drones may limit the commercial drone market’s expansion. Safety is a fundamental element to prioritize when operating drone technology. UAVs outfitted with high-quality sensors recognize possible collisions and safely engineer their way around them, making them a significant trait. These drone capacities must resemble those of manned aircraft navigators. It is commendable to hire professional drone service providers who can operate an aerial drone without crashing it. Drones operated in heavily-populated regions have an amplified risk of ground impact or damage, mainly due to system malfunction or hacking. Drones also pose a significant danger to aircraft as they can be sucked into the turbines of aircraft if there is a proximity between them, causing significant damage to the propulsion systems. The drones could be hijacked by tampering with the frequency-hopping sensors used in devices that use radio communications. The safety and privacy concerns related to drones are expected to hamper the growth of the market in focus during the forecast period.

Global Drone Sensor Market Segmental Overview

The report analyses the global Drone Sensor Market based on product type, surgery, indication, application and region.

Global Drone Sensor Market by Sensor Type

Based on the sensor type, the Drone Sensor industry is divided into Inertial Sensor, Image Sensor, Speed & Distance Sensor, Position Sensor, Pressure Sensor, Light Sensor, Current Sensor, and Others. Of these, the inertial sensor segment registered significant revenue in 2021 attributed to the Increasing advancement and availability of different types of inertial sensor including accelerometers, gyroscope, magnetometers, and tilt will foster the industry growth in the upcoming year. Inertial sensors are tiny chips that can be integrated into many consumer devices. This reduction in size and weight has been exploited to the full in the aeronautical industry, where sensor manufacturers produce units that can be integrated in UAV flight control systems. This sensor are used for a variety of applications in UAVs and drones. They allow the aircraft to maintain stability and control while experiencing high winds or performing steep turning manoeuvres.

Global Drone Sensor Market by Platform Type

By platform type, the industry is divided into VTOL, Fixed-Wing, and Hybrid. The hybrid segment of the Drone Sensor market is expected to grow at a rapid pace through 2030. This is attributed to the hybrid commercial drones use the advantages of batteries and fuel combined to maximize their power and efficiency. Additionally, these drones fly for a longer duration with higher payloads even in adverse weather conditions. Hybrid platform can carry a variety of payloads that make them suitable for a wide range of long-endurance and heavy-lift applications, such as mapping and surveying, military intelligence, surveillance and reconnaissance (ISR), cargo delivery and precision agriculture. Since the hybrid drone is capable of almost all-terrain movements like flying, perching, driving, climbing, and vertical take-off and landing, its developers have tuned it to perform professional missions for search and rescue, patrolling, monitoring, and industrial intralogistics in various, difficult conditions.

Global Drone Sensor Market by Application

Based on indication, the Drone Sensor industry is categorized into Navigation, Collision Detection & Avoidance, Data Acquisition, Motion Detection, Air Pressure Measurement, and Others. The navigation segment accounted for lucrative market share in 2021. This is owing to the navigation segment was valued at USD 191.8 million in 2021 and it is anticipated to grow further to USD 1,241.4 million by 2031, at a CAGR of 20.0% during the forecast period.

Electronic compasses in drones give inertial navigation and guidance systems crucial directional data. Drone applications benefit from the improved accuracy and response time features of anisotropic magneto resistive (AMR) permalloy technology sensors, which use substantially less power than competing technologies. Manufacturers of drones can get high-quality data sensing from turnkey solutions in a highly durable and small design. Different companies are launching navigation sensors to expand their product portfolio. For instance, in March 2022, Honeywell Unveils MV60, A new precision navigation sensor for aerospace and beyond. Aerospace, industrial, and marine industries can benefit from a rugged, low-cost navigation solution that does not compromise performance.

Global Drone Sensor Market by End-user

Based on the end-user, the industry is categorized into Construction, Media & Entertainment, Precision Agriculture, Personal, Security & Surveillance, Defense, Law Enforcement, Transportation, and Others. The construction segment was valued at USD XX million in 2021 and it is anticipated to grow further till USD XX million by 2031 at a CAGR of XX% during the forecast period. The drone helps in collecting aerial footage of the construction site before, during, and after the project as per requirement and easing tasks. The advantage of using drones over the manual construction method is the fact that is saves time, and effort and reduces the risk involved. Drones are a viable tool that offers benefits ranging from on-site safety to remote monitoring. It provides construction contractors with broad, accurate and detailed aerial information.

Numerous expedited building projects have already received funding. However, other regions with lesser budgets and decreased tax revenues have stopped expenditure and put a stop to construction projects. The long-term challenges for the global construction business will come from poor GDP growth, rising unemployment, and stagnant commercial projects. Construction enterprises experiencing a financial problem would not be able to make an early investment in a drone programme, even if drone operations might ultimately save resources and save money.

Geographical Analysis of Global Drone Sensor Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Drone Sensor market is poised to witness significant growth rate through 2030. Some of the key factors contributing to the leading position of North America region in the global drone sensor market include rising adoption and skyrocketing demand for efficient drones from the regional military and defence sectors, high rate of new technology integration in commercial products in Canada as well as the United States, and high usage of smart agricultural equipment, which includes precision farming drones. Furthermore, the equipment is being used in multiple applications by the United States’ booming ICT industry. For example, Amazon stated in June 2019 that the company is interested in using drones to deliver packages. The Federal Aviation Administration has also given the company approval for its “prime air delivery” fleet. Due to the significant presence of drone sensor vendors in this region and favorable government regulations, the Asia Pacific drone sensors market growth is expected to accelerate at a substantial CAGR during the forecast period.

Major Players in the Global Drone Sensor Market

The key players in the market Trimble, Bosch Sensortec, TDK InvenSense, Sparton NavEx, Raytheon, AMS AG, Infineon Technologies, PrescisionHawk, Sentera, Inc., and SlantRange., among others.

COVID-19 Impact:

The COVID-19 pandemic outbreak has posed unprecedented challenges to governments and communities around the world. During the early phases of the pandemic, with most countries having imposed strict lockdowns to contain the coronavirus, authorities were looking for rapid and efficient solutions to deliver public goods and services. Drones, or unmanned aerial vehicles (UAVs), emerged as the optimal solution to the growing challenges. In Rwanda, Ghana, and Malawi, for instance, drones were deployed to deliver essential medical supplies to remote villages and towns. Private entities, too, stepped up. In April 2020, CVS and United Parcel Service (UPS) started delivering prescription medications to residents in a retirement community in Florida. Drone sensors are the most critical parts that help operators navigate these machines remotely and with UAVs proving instrumental amid the current crisis, the demand for sensors is likely to spike

Recent Developments:
  • In July 2022, Syngenta launched biodiversity sensor project with IIT Ropar
  • In June 2022, Collins Aerospace launched the first M-code-compatible navigation system for military ground vehicles available in Europe.
  • In March 2022, Honeywell launched Unveils MV60, A new precision navigation sensor for aerospace and beyond.
  • In November 2021, AgEagle Announces Launch of MicaSense’s Altum-PT An Optimized 3-in-1 Sensor Integrating Ultra-High Resolution, Panchromatic Imaging and Thermal Imaging to Provide Unlimited Analytical Capabilities at Leaf-Level Resolution.
  • In November 2020, the US Department of Defense awarded General Atomic a USD 93.3 million contract to develop drone sensors for the MQ-9 Reaper. Both sides have agreed to work together.
Drone Sensor Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Drone Sensor Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Drone Sensor Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Drone Sensor Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the Drone Sensor Market?

Ans. The global Drone Sensor Market was valued at USD 568.2 Million in 2021 and it is anticipated to grow up to USD 4,032.8 Million by 2031, at a CAGR of 21.1% during the forecast period.

Q2. What is the Drone Sensor Market growth rate?

Ans. The growth rate of the Drone Sensor Market is 21.1%.

Q3. Whichregion holds a major market share for the market?

Ans. North America holds a major market share of the Drone Sensor Market in 2021.

Q4. Which segment accounted for the largest Drone Sensor Market share?

Ans. By end-user, defense segment accounted for the largest Drone Sensor Market share.

Q5. Who are the key players in the Drone Sensor Market?

Ans. The global Drone Sensor Market report includes players such as Trimble, Bosch Sensortec, TDK InvenSense, Sparton NavEx, Raytheon, AMS AG, Infineon Technologies, PrescisionHawk, Sentera, Inc., and SlantRange., among others

Q6. What are the factors driving the Drone Sensor Market growth?

Ans. The major factors driving the growth of the market are Rapid technological advancements in drone sensor technique.

Q7. What are the key growth strategies of Drone Sensor Market players?

Ans. The key growth strategies of Drone Sensor Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Drone Sensor Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Drone Sensor Market during the forecast period.

Read More
Single User License

Hyperparathyroidism – Drug Pipeline Landscape, 2022
November, 2022

Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone, an 84–amino acid polypeptide hormone. The secretion of parathyroid hormone is regulated directly by the plasma concentration of ionized calcium. Primary hyperparathyroidism is a common endocrine disorder caused by overactivation of parathyroid glands resulting in excessive release of parathyroid hormone.

Secondary hyperparathyroidism mainly occurs when the calcium proportion in the body is dropped or reduced due to certain core ailments. Prolonged kidney illness also results in lowering Vitamin D and calcium, which results in secondary hyperparathyroidism.

The most common cause of hyperparathyroidism is having a long history of calcium and vitamin deficiencies, chronic kidney failure that results in low vitamin D and calcium levels.

Symptoms of hyperparathyroidism includes exhaustion, weakness of muscle and joints, body pains, loss of appetite, constipated bowels, motion sickness, fatigue, unable to concentrate and confusion, depression, nausea and vomiting, kidney stones etc.

Doctors most often diagnose hyperparathyroidism by general medical examination of the skin, eye, throat, pulse rate. A blood test is performed to detect the calcium level and hormone level of thyroid-stimulating Hormone including T3 and T4. CT, MRI, and Ultrasound Scans are conducted to detect the presence of a tumour or the swelling of the gland.

The most common investigative treatments include are few antithyroid and radioactive iodine medication is taken to control the overproduction of parathyroid hormone. In extreme cases, surgery is performed to remove the thyroid gland. Symptoms can be eased through lifestyle changes and home remedies like Regular walk and exercise for stronger and healthy bones., Intake of more water and fresh fruit juice to avoid dehydration., Having a balanced diet including Vitamin D-rich food and calcium supplements.

Report Highlights

Global Insight Service’s, Hyperparathyroidism – Drug Pipeline Landscape, 2022 report provides an overview of the Hyperparathyroidism pipeline drugs. This report covers detailed insights on Hyperparathyroidism drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Hyperparathyroidism pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Male Hypogonadism – Drug Pipeline Landscape, 2022
November, 2022

Male Hypogonadism is characterized by a decrease in testosterone level or lack of spermatozoa production or both. When a disorder related to the testes it is called primary hypogonadism or if it related to the hypothalamic-pituitary axis it is called secondary hypogonadism.

Causes of hypogonadism include HIV or AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles, and untreated sleep apnea.

Symptoms of hypogonadism include fatigue, hot flashes, infertility, decrease in muscle mass, and loss of bone mass

Doctor diagnose hypogonadism based on a physical exam, a review of symptoms, and the results of multiple blood tests which will detect low testosterone levels.

Male hypogonadism is usually treated with testosterone replacement to return testosterone levels to normal and natural therapies which will increase testosterone production including diet and exercise, weight loss, improved sleep.

Report Highlights

Global Insight Service’s, Male Hypogonadism – Drug Pipeline Landscape, 2022 report provides an overview of the Male Hypogonadism pipeline drugs. This report covers detailed insights on Male Hypogonadism drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Male Hypogonadism pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Migraine – Drug Pipeline Landscape, 2022
November, 2022

Migraine is a neurological disorder that is associated with recurrent headaches. The headache is characterized by affecting one side of the head, pulsating, moderate to severe in intensity which last for few hours to three days.

The underlying cause of migraine is unknown. It is believed that, migraine may be due to a mixture of environmental triggers and genetical factors. Change in hormonal levels during puberty may also affect the cause of migraine. Triggering factors include fatigue, certain foods, alcohol, and whether. Psychological stress quoted to be a risk factor.

The symptoms of migraine is presented one or two days before the attack, which is presented as constipation, mood changes, fatigue, fluid retention, frequent yawning, and increased urination. Few people experience migraine aura, including visual phenomena, vision loss, pins and needles sensation in arm and legs, weakness or numbness in the face and difficulty speaking. Symptoms during migraine attack includes pain on one of the head, pain throbbing or pulsing, sensitivity to light, sound, smell and touch, and also experience nausea and vomiting.

The migraine diagnosis is based on medical history, symptoms, physical and neurological examination, Neuroimaging tests are used to find other causes of headaches which includes MRI and CT scans.

The treatment plan of migraines includes the combination of lifestyle adjustments, OTC pain or migraine medications like NSAIDs, triptans, dihydroergotamine, CGRP antagonists, opioid medications, anti-nausea drugs, alternative care includes meditation, acupressure or acupuncture.

Report Highlights

Global Insight Service’s, Migraine – Drug Pipeline Landscape, 2022 report provides an overview of the Migraine pipeline drugs. This report covers detailed insights on Migraine drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Migraine pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Teeth Whitening Market
November, 2022

The global teeth whitening market was valued at USD 6645 million in 2021 and it is anticipated to grow further till USD 10126 million by 2031, at a CAGR of 4.3% during the forecast period.

The popular cosmetic dental technique of teeth whitening is a successful method for removing surface stains from teeth. Both essential and non-essential whitening are included. While non-vital whitening is done on teeth without living nerves, vital whitening is done on teeth that have live nerves. Too much coffee, fizzy drinks, and sugary foods and drinks cause teeth to become stained. These stains can be removed using teeth-whitening products like whitening toothpaste, whitening gel & strips, whitening light devices, and whitening pens.

Global Teeth Whitening Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 6645 Million
Market Size in 2031US$ 1012 6Million
CAGR %4.3%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Distribution Channel, and Region
Key CompaniesBrodie & Stone, Church & Dwight Co. Inc., Colgate-Palmolive Company, Dr. Fresh LLC, GlaxoSmithKline PLC, GLO Science, Henkel AG & Co. KGaA, Johnson & Johnson, Unilever, Proctor & Gamble, GoSmile LLC, Ultradent Products Inc., and REMBRANDT among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Drivers and Trends

People all over the world are now more aware of the importance of dental and oral health due to an increased focus on personal hygiene and physical attractiveness. The perception of white teeth as an attractive physical appearance attribute is anticipated to increase consumer focus on appearances and drive sales of teeth whitening solutions. To broaden their range of use and boost their capacity for generating cash, tooth whitening strip manufacturers have introduced sensitive teeth strips. Shipments of teeth whitening strips are anticipated to increase in the next years as a result of rising cosmetic dentistry demand and the expansion of over-the-counter bleaching options.

Market Restraints and Challenges

When the COVID-19 epidemic first started, dental services were one of the worst hit. Dental offices all throughout the world were shut down. Several dental surgeons had to deal with unexpected difficulties due to a lack of patient visits and decreased profits. Telemedicine, however, turned out to be helpful for patients as well as dentists. In the United States, private dental insurance is said to be used by 70% of all dental patients. There is a significant chance that demand for dental care could stagnate due to economic factors given the high unemployment rates anticipated in the upcoming months.

Global Teeth Whitening Market Segmental Overview

The report analyses the global teeth whitening market based on the product, distribution channel, and region.

Global Teeth Whitening Market by Product

Based on the product, it is segmented into whitening toothpaste, whitening gels & strips, light teeth whitening device, and others. The whitening toothpaste segment is anticipated to dominate the market during the forecast period. Due to their low cost and the presence of major manufacturers like P&G and Colgate Palmolive in the market, whitening toothpaste accounted for the biggest market share. Additionally, active charcoal toothpaste has been developed, which is highly absorbent and efficient in eliminating dental stains. However, since whitening toothpaste only includes a small amount of hydrogen peroxide, teeth only become two times as white as before.

Global Teeth Whitening Market by Distribution Channel

Based on the distribution channel, it is segmented into online, and offline. The offline segment is anticipated to dominate the market during the forecast period. Because they are primarily distributed through offline channels like retail stores, goods like whitening toothpaste and strips have a large market share. However, sales made through the web network are expanding incredibly quickly—six times faster. The availability of whitening goods through internet channels has increased, according to companies like Colgate and P&G. Colgate’s eCommerce sales grew by 26% globally in 2019 and grew significantly in North America. Online retailers also provide a selection of goods at reasonable costs. Their popularity is growing as a result. Colgate built its own Online Acceleration centre in the UK in 2019 to further boost its online channel. that creates digital material for the business.

Geographical Analysis of the Global Teeth Whitening Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. North America region is anticipated to dominate the market during the forecast period. Because of the development of technology and the rise in the number of people choosing to undergo teeth-whitening procedures. The area has a high level of oral health awareness, and the number of persons choosing aesthetic operations has increased. The forecast period is expected to see the greatest growth in Asia Pacific and the highest CAGR. This is mostly because growing nations like China and India are producing an increasing amount of disposable cash. Due to the large population density in this area, many people are motivated to aesthetically improve oral health. Additionally, the increased incidence of dental diseases like periodontitis, which contributes to teeth discoloration, is pushing consumers to choose teeth whitening operations and expanding the market for the sector.

Major Players in the Global Teeth Whitening Market

The report analyses the various key players such as Brodie & Stone, Church & Dwight Co. Inc., Colgate-Palmolive Company, Dr. Fresh LLC, GlaxoSmithKline PLC, GLO Science, Henkel AG & Co. KGaA, Johnson & Johnson, Unilever, Proctor & Gamble, GoSmile LLC, Ultradent Products Inc., and REMBRANDT among others.

COVID-19 Impact

The greater emphasis on personal hygiene and at-home dental aesthetics that has been brought about by the COVID-19 pandemic is in the limelight. The greatest risk of acquiring and spreading COVID-19 is among dental surgeons, paramedics, nurses, and other healthcare workers. Dental offices have been closing around the world for the past few months. The epidemic has altered how people obtain healthcare globally, and dental care is no different. People are increasingly in need of at-home teeth whitening treatments as social isolation persists throughout the world and prevents them from visiting their neighborhood dentist for routine or aesthetic dental procedures. A large variety of goods, including toothpaste, films, and gels, are readily available over-the-counter and online, increasing their uptake and having a favourable effect on the market’s expansion during the pandemic. Additionally, according to a study that was published in the British Dental Journal 2020, maintaining excellent dental hygiene is seen to be the most effective strategy to protect patients from airway infections, particularly COVID-19 patients. Since most of the comorbidities linked to an elevated risk of difficulties in COVID-19 are also linked to oral biofilms and periodontal disease, the study recommended more research into the relationship between oral microbiomes and COVID-19 complications. As a result of the aforementioned considerations, it is anticipated that the pandemic will have a substantial influence on the market under study.

Recent Developments
  • January 2022, Oral-B unveiled its latest digital health innovations at the 2022 Consumer Electronics Show (CES), including its CES Innovation Award Honoree Oral-B iO10 with iOSense, which serves as the ultimate oral health coach.
  • April 2021, GSK Consumer Healthcare launched its global toothpaste brand Parodontax in India to strengthen its oral care portfolio.
  • April 2020, Oralgen NuPearl launched its new Oralgen Probiotic Oral Care Whitening Toothpaste, clinically proven to balance healthy bacteria in the mouth and to smile bright with a gentler, fluoride-free formula.
  • February 2020, Wellness, launched its new all-natural whitening toothpaste, which is glycerin and fluoride free and comprises calcium carbonate, peppermint, stevia leaf, and green tea leaf extract.
Frequently Asked Questions

Q1. How big is the Teeth Whitening market?

Ans. The global Teeth Whitening market size was USD 6645 million in 2021 and is anticipated to reach USD 10126 million in 2031, growing at a rate of 4.3% from 2022 to 2031.

Q2. What is the Teeth Whitening market growth rate?

Ans. The growth rate of the Teeth Whitening market is 4.3%.

Q3. Which region holds a major market share for the Teeth Whitening market?

Ans. North America holds a major market share of the Teeth Whitening market in 2021.

Q4. Which segment accounted for the largest Teeth Whitening market share?

Ans. By distribution channel, the offline segment accounted for the largest Teeth Whitening market share.

Q5. Who are the key players in the Teeth Whitening market?

Ans. The global Teeth Whitening market report includes players such as Brodie & Stone, Church & Dwight Co. Inc., Colgate-Palmolive Company, Dr. Fresh LLC, GlaxoSmithKline PLC, GLO Science, Henkel AG & Co. KGaA, Johnson & Johnson, Unilever, Proctor & Gamble, GoSmile LLC, Ultradent Products Inc., and REMBRANDT among others.

Q6. What are the factors driving the Teeth Whitening market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Teeth Whitening market players?

Ans. The key growth strategies of Teeth Whitening market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Teeth Whitening market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Teeth Whitening market during the forecast period.

Read More
Single User License

Pedicle Screw Systems Market
November, 2022

The global Pedicle Screw Systems Market was valued at USD 2.3 billion in 2021 and it is anticipated to grow up to USD 4.4 billion by 2031, at a CAGR of 6.7% during the forecast period.

A pedicle screw system is a device that is used to fixate the spine. It consists of two main components: pedicle screws and rods. Pedicle screws are inserted into the pedicles of the vertebrae and are secured in place with rods. This system is used to treat a variety of spine conditions, including scoliosis, kyphosis, and spondylolisthesis. It is also used in spinal fusion surgery.

Global Pedicle Screw Systems Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$2.3bn
Market Size in 2031$4.4bn
Growth Rate (2021-31)6.7%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct Type, Surgery, Indication, Application and Region
Key CompaniesMedtronic plc, Aesculap Implant Systems LLC, Alphatec Holdings Inc., DePuy Synthes Inc. ,Evolution Spine LLC, Exactech Inc., Globus Medical Inc., Implanet SA, Life Spine Inc. and NuVasive Inc.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The rising number of spinal cord injuries will drive the demand for pedicle screw systems.

Increasing cases of spinal cord injuries are expected to increase market demand. According to the National Spinal Cord Injury Statistical Center at the University of Alabama at Birmingham (UAB), approximately 17,730 new spinal cord injury cases are reported each year in the United States. As a result, the growing number of spinal disease cases have a severe impact on the economy and society, necessitating rapid medical attention.

Market Restraints and Challenges

The high cost of spine fusion surgery may limit market expansion during the predicted period. The usual cost of spinal fusion, which is commonly used to address issues such as a slipping vertebra, fractured vertebra, or other spinal instability, ranges from USD 80,000 and USD 150,000 or more, depending on the surgeon’s charge. Moreover, the surgeon’s charge varies depending on the type of operation, qualifications, and skill of the individual doing the therapy.

Furthermore, the cost of the surgery is determined by a few aspects, such as the choice between operative and non-operative treatment for adult and geriatric spinal deformity. Such choices are influenced by elements such as the degree and kind of the patient’s symptoms, as well as the size and risk of potential complications.

Global Pedicle Screw Systems Market Segmental Overview

The report analyses the global Pedicle Screw Systems Market based on product type, surgery, indication, application and region.

Global Pedicle Screw Systems Market by Product Type

Based on the product type, the pedicle screw systems industry is bifurcated into monoaxial pedicle screw, polyaxial pedicle screw, and others. Of these, the tablets, and capsules segment registered significant revenue in 2021 attributed to the growing success rate of spinal fusion surgeries. The pedicle screw systems are implanted on patients who suffer from diseases such as spondylolisthesis, degenerative disk disease, fractured vertebra, spinal stenosis, scoliosis, herniated disk, infection, and tumor. In addition, for rods, cages, and plates fixation, pedicle screws are required of different lengths and diameters. These screws stabilize the spine and provide extra support to the implant.

Global Pedicle Screw Systems Market by Surgery

By surgery, the industry is divided into open surgery, and minimally invasive surgery. The open surgery segment of the pedicle screw systems market is expected to grow at a rapid pace through 2030 due to the rising reported cases of spinal deformities attributed to spinal injuries, infection, spinal cancer, and degenerative disc diseases. As per estimates, over 1.6 million spinal surgeries are performed across the globe every year. Thus, the growing demand for the treatment of spinal diseases is one of the prominent factors fuelling the demand for pedicle screw systems and spinal surgeries. Also, rising success rate of spinal deformities surgeries is slated to influence the market demand for pedicle screw systems.

Global Pedicle Screw Systems Market by Indication

Based on indication, the pedicle screw systems industry is categorized spinal deformities, and spinal trauma. The spinal deformities segment accounted for lucrative market share in 2021. This is owing to the rising incidence rate of degenerative spinal diseases. As per the World Health Organisation (WHO) estimates, more than 413 million people are suffering from degenerative spine disease across the globe. Once the disc has degenerated, the degenerative process cannot be reversed through medication, therapy and other methods. Therefore, surgery is one of the best treatments or manageable solutions for degenerative diseases.

Global Pedicle Screw Systems Market by Application

Based on the application, the industry is categorized into cervical fusion, thoracolumbar, and lumber. Among these, the lumber segment is expected to depict significant CAGR from 2022 to 2030. Specialty stores are also emerging as a significant market segment, owing to the increasing reported cases of low back pain (LBP) in the population. Approximately 60-85% of adults suffer from LBP credited to the development of osteophytes in the geriatric population. Also, the spinal fracture incidence rate is around 5% to 6% and the highest cases of fracture are being reported of the thoracolumbar section, followed by the neck and lumbar vertebrae.

Geographical Analysis of Global Pedicle Screw Systems Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America pedicle screw systems market is poised to witness 2.9% growth rate through 2027. The presence of dominant market players and technologies associated with pedicle screw system is attributable to rise in demand for spinal surgeries. The availability of advanced spinal fusion techniques along with the accessibility of innovative implants in the region is set to drive the regional growth. High competition boosts the innovation rate, high quality goods, services and variety in the region which benefits the end-users.

Major Players in the Global Pedicle Screw Systems Market

The key players in the market Medtronic plcAesculap Implant Systems LLCAlphatec Holdings Inc.DePuy Synthes Inc. ,Evolution Spine LLCExactech Inc.Globus Medical Inc. Implanet SALife Spine Inc. and NuVasive Inc., among others.

COVID-19 Impact

The spread of COVID-19 pandemic across the globe has impacted the market negatively. Increase in number of COVID-19 infections across several countries has resulted in imposing of lockdown and delaying/postponing the necessary surgical procedures. The spinal fusion procedure was not one of the critical or life-saving procedure during the time and hence, opted as elective surgical procedures. Several countries across the globe were focusing on severe and life-threatening health conditions other than elective surgeries.

Recent Developments
  • In September 2021, Intelivation Technologies, launched the Golden Isles Pedicle Screw System during the 36th Annual NASS Meeting this week in Boston
  • In July 2020, CoreLink announced that it launched its Tiger MIS x-tab pedicle screw system designed for the correction of the thoracolumbar spine.
  • In June 2020, Precision Spine, Inc., announced the worldwide launch of the Reform® Ti Modular Pedicle Screw System for surgeons seeking increased flexibility, versatility, and visibility in degenerative and trauma procedures.
Pedicle Screw Systems Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Pedicle Screw Systems Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Pedicle Screw Systems Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Pedicle Screw Systems Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the Pedicle Screw Systems Market?

Ans. The global Pedicle Screw Systems Market size was USD 2.3 billion in 2021 and is anticipated to reach USD 4.4 billion in 2031, growing at a rate of 6.7% from 2022 to 2031.

Q2. What is the Pedicle Screw Systems Market growth rate?

Ans. The growth rate of the Pedicle Screw Systems Market is 6.7%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Pedicle Screw Systems Market in 2021.

Q4. Which segment accounted for the largest Pedicle Screw Systems Market share?

Ans. By application, segment accounted for the largest Pedicle Screw Systems Market share.

Q5. Who are the key players in the Pedicle Screw Systems Market?

Ans. The global Pedicle Screw Systems Market report includes players such as Medtronic plcAesculap Implant Systems LLCAlphatec Holdings Inc.DePuy Synthes Inc. ,Evolution Spine LLCExactech Inc.Globus Medical Inc. Implanet SALife Spine Inc. and NuVasive Inc., among others

Q6. What are the factors driving the Pedicle Screw Systems Market growth?

Ans. The major factors driving the growth of the market are Rapid technological advancements in minimally invasive surgery (MIS) technique.

Q7. What are the key growth strategies of Pedicle Screw Systems Market players?

Ans. The key growth strategies of Pedicle Screw Systems Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Pedicle Screw Systems Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Pedicle Screw Systems Market during the forecast period.

 

Read More
Single User License

Trauma Fixation Devices Market
November, 2022

The global trauma fixation devices market was valued at USD 6.5 billion in 2021 and it is anticipated to grow up to USD 11.0 billion by 2031, at a CAGR of 5.4% during the forecast period.

Trauma fixation devices are devices that are used to stabilize bones and soft tissue in order to allow the body to heal from injuries. These devices can be external or internal, and are typically made from metal or plastic. External devices include casts and splints, while internal devices include screws, plates, and pins.

Global Trauma Fixation Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$6.5bn
Market Size in 2031$11.0 bn
Growth Rate (2021-31)5.4%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, Material, Site, End-use and Region
Key CompaniesZimmer Biomet Holdings, Inc., Stryker Corporation, Johnson and Johnson (DePuy Synthes), Wright Medical Group, Inc., Orthofix International N.V., Cardinal Health Inc, Medtronic, Integra LifeSciences, Double Medical Technology Inc., and Citieffe S.R.L.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Growing incidence of road accidents across the globe will boost the market expansion

Rising incidence of road accidents is estimated to propel the trauma fixation devices market progression. According to the World Health Organization (WHO), approximately 1.25 million fatalities are observed annually due to road traffic accidents and crashes. An additional 20-50 million people suffer from non-fatal injuries, with many incurring physically disabilities. Thus, road traffic accidents are considered as one of the leading causes of death and disability across the globe.

Market Restraints and Challenges

Trauma fixation devices are used for complex surgical procedures. Moreover, handling the latest technologically advanced products requires skilled professionals. However, the lack of trained professionals to operate advanced trauma fixation devices is anticipated to cause hindrance in the industry expansion. Furthermore, the novel trauma fixation devices are associated with complex surgical procedures requiring skilled healthcare professionals to operate, thus hampering the industry progression. With majority of the underdeveloped and developing economies lacking the adequate human and infrastructural resources, it is predicted to hamper the industry demand to certain extent over the coming years.

Global Trauma Fixation Devices Market Segmental Overview

The report analyses the global Trauma Fixation Devices Market based on Product, Material, Site, End-use and Region.

Global Trauma Fixation Devices Market by Product

Based on the product, the trauma fixation devices industry is bifurcated into external fixators, internal fixators, and others. Of these, the internal trauma fixation devices segment registered significant revenue in 2021. This is owing to the high patient preference towards internal fixators owing to its better procedural outcome. Additionally, internal fixators allow rapid recovery and shorter hospital stays, thereby influencing the market demand. In addition, internal fixators also reduce the chances of improper healing of broken bones, thereby fostering the industry value. Various players are focusing on development of biocompatible devices, thereby leading to the market revenue.

Global Trauma Fixation Devices Market by Material

By material, the industry is divided into stainless steel, titanium, and others. The stainless steel segment of the trauma fixation devices market is expected to grow at a rapid pace through 2030. Stainless steel is one of the important materials used in the fabrication of internal fixation implants due to its quality such as high corrosion resistance under oxygen-rich environment as compared to other biomaterials. In addition, it is also cost effective in nature, further contributing to the material’s high adoption. Furthermore, countries with low income or limited insurance coverage mostly prefer usage of stainless-steel attributed to its cost-effective nature, thereby contributing to the segment expansion.

Global Trauma Fixation Devices Market by Site

Based on site, the trauma fixation devices industry is categorized lower extremities and upper extremities. The lower extremities segment accounted for lucrative market share in 2021. This is owing to the Bone degenerative diseases such as osteoporosis, arthritis and others that cause friction between the joints and ultimately reduces bone strength leading to rapid injuries.

Global Trauma Fixation Devices Market by End-user

Based on the end-user, the industry is categorized into hospitals, ambulatory surgical centers, orthopedic centers, and others. Among these, the hospital segment is expected to depict significant CAGR from 2022 to 2030 attributed to the growing incidence of injuries related to sports and hike in number of road accidents. Moreover, increasing number of multispecialty hospitals with an aim to provide appropriate treatments for trauma injuries, mostly in the developing countries including India will propel the industry revenue. Additionally, cost effective treatments provided by various government hospitals in low-income countries will act as major market expansion fuelling factors.

Geographical Analysis of Global Trauma Fixation Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America trauma fixation devices market is poised to witness significant growth rate through 2027. Presence of major market leaders such as Stryker Corporation, Johnson and Johnson will significantly drive the North America market. Moreover, rising prevalence of orthopedic diseases including osteoporosis and rheumatoid arthritis will show a positive growth trajectory of trauma fixation devices. As arthritis is the leading cause of disability among the population, it increases the demand for trauma fixation devices in the countries of North America.

Major Players in the Global Trauma Fixation Devices Market

The key players in the market Zimmer Biomet Holdings, Inc.Stryker CorporationJohnson and Johnson (DePuy Synthes)Wright Medical Group, Inc.Orthofix International N.V.Cardinal Health IncMedtronicIntegra LifeSciencesDouble Medical Technology Inc., and Citieffe S.R.L, among others.

COVID-19 Impact

The COVID-19 pandemic has severely impacted the global economies with all the sectors witnessing a significant slump during 2020. The healthcare sector was one of the most severely impacted sectors as the pandemic put a tremendous pressure on the healthcare systems to contain the spread of infection. Due to the non-essential nature of trauma fixation procedures, many treatments and surgical procedures were noted to be suspended or postponed indefinitely during pandemic. Thus, low demand was observed for trauma fixation devices amidst the initial months of pandemic, thereby hampering the industry growth.

Recent Developments
  • In June 2022, Paragon 28, Inc. announced the launch of its Monkey Rings™ Circular External Fixation System for trauma, deformity correction, and limb salvage. The Monkey Rings Circular External Fixation System is designed to use external wires and screws that can be fixed into bone to maintain anatomic position while providing stability, preservation of soft tissue, and allow for adjustability and functionality.
  • In August 2021, OrthoGrid Systems, Inc., announced the launch of its new OrthoGrid Trauma Application. The new OrthoGrid Trauma is the latest application of OrthoGrid’s Surgical Digital Platform.
  • In July 2021, Endeavor Orthopedics received the 510k approval from the US FDA for their Summit Patella Plating System. This system is indicated in the surgical stabilization of patella fractures during open reduction internal fixation procedures in adults.
  • In June 2021, Zimmer Biomet launched Bactiguard-coated trauma implants for infection prevention in select Europe and the Middle East and Africa markets. In January 2021, these implants received the CE mark.
  • In June 2018, DePuy Synthes announced the launch of the Femoral Recon Nail System in the U.S. for treatment of thigh bone fractures, expanding the company’s trauma portfolio for patients suffering from hip and femur fractures.
  • In May 2018, the company announced a definitive agreement to acquire the assets of Medical Enterprises Distribution, LLC, a developer of surgical impactor technology, to further develop surgical impactor technology for orthopedic surgical procedures.
Trauma Fixation Devices Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Trauma Fixation Devices Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Trauma Fixation Devices Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Trauma Fixation Devices Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the trauma fixation devices market?

Ans. The global trauma fixation devices market size was USD 6.5 billion in 2021 and is anticipated to reach USD 11.0 billion in 2031, growing at a rate of 5.4% from 2022 to 2031.

Q2. What is the trauma fixation devices market growth rate?

Ans. The growth rate of the trauma fixation devices market is 5.4%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Trauma Fixation Devices Market in 2021.

Q4. Which segment accounted for the largest trauma fixation devices market share?

Ans. By end-user, hospital segment accounted for the largest trauma fixation devices market share.

Q5. Who are the key players in the trauma fixation devices market?

Ans. The global trauma fixation devices market report includes players such as  Zimmer Biomet Holdings, Inc.Stryker CorporationJohnson and Johnson (DePuy Synthes)Wright Medical Group, Inc.Orthofix International N.V.Cardinal Health IncMedtronicIntegra LifeSciencesDouble Medical Technology Inc., and Citieffe S.R.L., among others.

Q6. What are the factors driving the trauma fixation devices market growth?

Ans. The major factors driving the growth of the market are growing technological advancements in trauma fixation devices coupled with increasing rate of geriatric population

Q7. What are the key growth strategies of trauma fixation devices market players?

Ans. The key growth strategies of trauma fixation devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Trauma Fixation Devices Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Trauma Fixation Devices Market during the forecast period.

Read More
Single User License

Artificial Cervical Intervertebral Disk Market
November, 2022

The global artificial cervical intervertebral disc market was valued at USD 1621 million in 2021 and it is anticipated to grow further till USD 8480 million by 2031, at a CAGR of 18.0% during the forecast period.

The cervical intervertebral disc has the ability to absorb a huge compressive load while providing different types of motion between the bones in the neck. Market players have developed various artificial intervertebral cervical discs which are used to treat cervical disc problems. An artificial cervical disc replaces the movement and cushioning function of the damaged cervical disc.

Global Artificial Cervical Intervertebral Disc Market Scope and Report Structure
Report AttributeDetails
Market Size in 2021US$ 1621 Million
Market Size in 2031US$ 8480 Million
CAGR %18.0%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredMaterial, End User, and Region
Key CompaniesZimmer Biomet Holdings, Inc., Globus Medical, Inc., Centinel Spine, LLC., Synergy Spine Solutions, Inc., B. Braun Melsugen AG, Aditus Medical, AxioMed LLC, NuVasive, Inc., and Medtronic among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The rising geriatric population is anticipated to boost the growth of the global artificial intervertebral cervical disc market. The aging process affects the cervical spine, neck, shoulders, upper back, and arms. Cervical spondylosis is a term for age-related wear and tear of the spinal disks in the neck. It is a common disease and worsens with age. As per the American Academy of Orthopedic surgeons, ~85% of people with age more than 60 are affected by cervical spondylosis. With age, the vertebral discs, which serve as shock absorbers, gradually dry out and affect the strength. As per the Fact Sheet: Aging in the United States, the number of individuals in aged 65 and older is estimated to reach ~95 million by 2060 from 52 million in 2018, and its share in the total population is anticipated to spike up to 23% from 16%.

Market Restraints and Challenges

All elective procedures, including spine surgeries, were delayed between 17 March 2020 and 8 June 2020, and the hospital was transformed into a recognized COVID-19 treatment facility. As a result, these issues are having a detrimental effect on the market expansion. The demand for healthcare-related items, particularly spinal surgical products, is expected to increase as a result of healthcare reforms that are increasing access to treatments for a larger portion of the populace in many emerging markets. The demand for these products will continue to rise as economic prosperity in important developing regions rises, which will further fuel market expansion.

Global Artificial Cervical Intervertebral Disc Market Segmental Overview

The report analyses the global artificial cervical intervertebral disc market based on the material, end user, and region.

Global Artificial Cervical Intervertebral Disc Market by Material

Based on the material, it is segmented into biopolymer material, and metal materials. The biopolymer segment is anticipated to dominate the market during the forecast period. The growth is primarily attributed to the biocompatibility and ease of insertion offered by biopolymer material discs. However, the metal material segment is anticipated to register the highest CAGR during the forecast period.

Global Artificial Cervical Intervertebral Disc Market by End User

Based on the end user, it is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is anticipated to dominate the market during the forecast period. The incidence of sports and active participation in fitness activities owing to the growing focus on healthy living across the globe. Adding to that, as per the National Spinal Cord Injury Statistical Center, diving is the fifth leading cause of severe cervical spinal cord injury. So, the demand for the artificial cervical intervertebral disc is boosting owing to increasing incidences of cervical injuries.

Geographical Analysis of the Global Artificial Cervical Intervertebral Disc Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North America region is accounted to hold the majority of market share during the forecast period. The growth of the region is primarily attributed to the increasing aging population and the rising number of product approvals and developments.

Major Players in the Global Artificial Cervical Interventional Disc Market

The major player analyzed in the report are Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Centinel Spine, LLC., Synergy Spine Solutions, Inc., B. Braun Melsugen AG, Aditus Medical, AxioMed LLC, NuVasive, Inc., and Medtronic among others.

COVID-19 Impact

The COVID-19 pandemic has impacted everyone in the world and is still spreading. The outbreak has impacted healthcare operations as well, causing non-essential treatments and procedures to be suspended or delayed. To stop the virus from spreading, the manufacturing sector is also concentrating on producing more critical protective gear and apparel. As a result, the CTDR device market may experience slower growth than usual in the near future.

Recent Developments
  • April 2021, NuVasive’s simplify disc received FDA approval for two-level cervical total disc replacement.
  • November 2019, FDA approved Orthofix’s M6-C Artificial Cervical Disc for Cervical Disc Degeneration treatment. The disc was developed by Spinal Kinetics, a company Orthofix acquired last spring.
  • March 2018, Orthofix announced agreement to acquire Spinal kinetics.
Frequently Asked Questions

Q1. How big is the Artificial Cervical Intervertebral Disc market?

Ans. The global Artificial Cervical Intervertebral Disc market size was USD 1621 million in 2021 and is anticipated to reach USD 8480 million in 2031, growing at a rate of 18.0% from 2022 to 2031.

Q2. What is the Artificial Cervical Intervertebral Disc market growth rate?

Ans. The growth rate of the Artificial Cervical Intervertebral Disc market is 18.0%.

Q3. Which region holds a major market share for the Artificial Cervical Intervertebral Disc market?

Ans. North America holds a major market share of the Artificial Cervical Intervertebral Disc market in 2021.

Q4. Which segment accounted for the largest Artificial Cervical Intervertebral Disc market share?

Ans. By end user, the hospitals segment accounted for the largest Artificial Cervical Intervertebral Disc market share.

Q5. Who are the key players in the Artificial Cervical Intervertebral Disc market?

Ans. The global Artificial Cervical Intervertebral Disc market report includes players such as Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Centinel Spine, LLC., Synergy Spine Solutions, Inc., B. Braun Melsugen AG, Aditus Medical, AxioMed LLC, NuVasive, Inc., and Medtronic among others.

Q6. What are the factors driving the Artificial Cervical Intervertebral Disc market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Artificial Cervical Intervertebral Disc market players?

Ans. The key growth strategies of Artificial Cervical Intervertebral Disc market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Artificial Cervical Intervertebral Disc market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Artificial Cervical Intervertebral Disc market during the forecast period.

Read More
Single User License

Interstitial Cystitis – Drug Pipeline Landscape, 2022
November, 2022

Interstitial cystitis also called painful bladder syndrome, is a chronic bladder problem usually related to bladder pressure and pain, with irregular pain in either the lower abdomen, pelvis or lower back. There are two types of interstitial cystitis: non-ulcerative interstitial cystitis and Ulcerative interstitial cystitis.

Causes of interstitial cystitis include age, chronic pain disorders, such as irritable bowel syndrome or fibromyalgia, and some of the factors contributing to interstitial cystitis are a defect of the epithelium layer of the bladder and leaking epithelium allows toxic agents in urine to irritate the bladder wall.

Interstitial cystitis is prone to affect women more than men. Common symptoms of interstitial cystitis include bladder pain and pressure, frequent urination, pain in the vagina or vulva in the case of women, and pain in the scrotum or testicles in the case of men.

Interstitial cystitis is diagnosed by Urine analysis and cystoscopy to look inside the urethra and bladder.

Interstitial cystitis is treated by non-steroidal anti-inflammatory drugs, antidepressants, and antihistamines.

Report Highlights

Global Insight Service’s, Interstitial Cystitis – Drug Pipeline Landscape, 2022 report provides an overview of the Interstitial Cystitis pipeline drugs. This report covers detailed insights on Interstitial Cystitis drugs under development, assessment by target, mechanism of action, route of administration and molecule type.Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Interstitial Cystitis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Reasons to Buy
    Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
    Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
    Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
    Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
Read More
Single User License

Vitreoretinal Surgery Devices Market
November, 2022

The global vitreoretinal surgery devices market was valued at USD 1.7 Billion in 2021 and it is anticipated to grow up to USD 2.5 Billion by 2031, at a CAGR of 3.9% during the forecast period.

Vitreoretinal surgery devices are used to treat conditions of the retina and vitreous, the clear, jelly-like substance that fills the inside of the eye. There are a variety of vitreoretinal surgery devices, including: Retinal detachment repair devices: These devices are used to repair a retina that has become detached from the back of the eye. Retinal detachment is a serious condition that can lead to blindness. Vitrectomy devices: These devices are used to remove the vitreous from the eye. Vitrectomy is often performed to treat conditions such as diabetic retinopathy and macular degeneration. Retinal prosthesis: A retinal prosthesis is an artificial device that is implanted in the eye to replace the function of the retina. Retinal prostheses are used to treat conditions such as retinitis pigmentosa and age-related macular degeneration.

Global Vitreoretinal Surgery Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$1.7 bn
Market Size in 2031$2.5 bn
Growth Rate (2021-31)3.9%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct, End-use, and Region
Key CompaniesAlcon, Inc., Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, MedOne Surgical, Inc., Carl Zeiss Meditec AG, Designs for Vision, Inc., Peregrine Surgical, D.O.R.C., Safilo Group, and Rodenstock.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The rapidly aging population is anticipated to spur the industry progression in the coming years. The WHO data estimates that the geriatric population is slated to double in the years from 2015 to 2050. The elderly population aged above 60 years is poised to showcase threefold growth during 2010 and 2050, reaching about 1.3 billion. Moreover, as per the United Nations Population Fund (UNFPA) estimates, by the year 2050, approximately 25% individuals in Asia Pacific region will be aged more than 60 years. Eye-related disorders are increasingly prevalent among the elderly population as aging affects vision and the ability to focus. The increasing elderly population affected with vision related conditions is set to fuel the vitreoretinal surgery devices market demand. The most frequent causes of vision impairment among the aging populace include the age-related macular degeneration, glaucoma, cataract, and diabetic retinopathy among others. Due to the increasing susceptibility and impaired vision, the prevalence of these disorders is commonly profound in people aged 60 and above.

Market Restraints and Challenges

Uncertain reimbursement scenario and high cost associated with the vitreoretinal surgery devices may negatively impact the market progression. The cost pertaining to the acquisition of vitreoretinal surgery devices may range from USD 5,000 to USD 15,000. The high cost associated with vitreoretinal surgery devices may limit the acceptance rate, thereby limiting the industry expansion. Owing to cost intensive nature of vitreoretinal surgeries, these medical procedures are reimbursed by the Medicare services. Despite of this reimbursement for the procedures, the reimbursement concerning vitreoretinal surgery devices is fairly uncertain that might restrict the industry demand.

Global Vitreoretinal Surgery Devices Market Segmental Overview

The report analyses the global vitreoretinal surgery devices market based on product, end-use, and region

Global Vitreoretinal Surgery Devices Market by Product

Based on product the market is segmented as Photocoagulation Lasers, Illumination Devices, Vitreoretinal Packs, Vitrectomy Machines, and Vitrectomy Probes. The photocoagulation lasers segment accounted for majority market share in 2021 and is anticipated to register a significant CAGR from 2022-20301. Photocoagulation lasers are applied in the treatment several eye disorders such the two leading causes of blindness in the U.S. including diabetic retinopathy and age-related macular degeneration. These precise laser-sourced devices reduce the risk of vision loss by cauterizing ocular blood vessels.

Global Vitreoretinal Surgery Devices Market by End-use

Based on end-use, the market is segmented as hospitals, specialty clinics, and ambulatory surgery centers. The ambulatory surgery centers. segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2031. This is owing wing to the growing number of vitreoretinal surgeries at ambulatory surgical centers. The increased usage of advanced and miniaturized vitreoretinal surgery devices reduced surgical time & increased convenience, and reduced instances of complications have minimized the requirement for hospitalization. Due to these developments, the number of vitreoretinal surgeries conducted in an outpatient setting has surged steadily that is expected to benefit the market share. In addition to this, the increasing pressure to minimize surging healthcare costs and availability of efficient equipment that limit the surgical complications including the reduced risks of catching the retina is further set to spur the industry demand.

Geographical Analysis of Global Vitreoretinal Surgery Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America held substantial revenue share in 2021. High acceptance of advanced devices and the rise in incidence of eye-related disorders that translates to increased vitreoretinal surgeries across the country. For instance, according to the Centers for Disease Control & Prevention statistics, an estimated 20.5 million citizens in the U.S. aged 40 years and above were suffering with cataract in one or both eyes, and around 6.1 million Americans had their lens removed surgically. The overall number of individuals with cataracts was further projected to reach to 30.1 million by 2020. Similarly, approximately 1.8 million Americans aged 40 years and above were affected by age-related macular degeneration (AMD) and an additional 7.3 million Americans are at considerable risk of developing AMD. Such adverse conditions along with aging population are predicted to impel the adoption rate of vitreoretinal surgery devices in the country.

Major Players in the Global Vitreoretinal Surgery Devices Market

The key players in the market  Alcon, Inc.Bausch & Lomb, Inc.OCULUS Optikgeräte GmbHMedOne Surgical, Inc.Carl Zeiss Meditec AGDesigns for Vision, Inc.Peregrine SurgicalD.O.R.C.Safilo Group, and Rodenstock, among others.

COVID-19 Impact

The COVID-19 pandemic has emerged as an unprecedented health concern that has rendered significant impact on the vitreoretinal surgery devices market value. The coronavirus outbreak has affected the global economy and several industrial structures including the healthcare sector. In order to minimize the further transmission of SARS-CoV-2 virus, national lockdowns were imposed, and emergencies were declared in several countries. Hospital admissions and services were offered to the COVID-19 affected patients on priority basis, with majority of the other medical procedures on halt. The U.S. declared a national emergency and postponed majority of the non-emergency surgical procedures in outpatient and inpatient settings. This has led to the delay in multiple medical procedures including vitreoretinal surgeries across various countries that has affected the market.

Recent Developments
  • In May 2021, MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space.
  • In July 2020, Alcon to showcased latest innovations, data at American Society of Retina Specialists 2020 virtual annual meeting.
  • In May 2019, Hoya Surgical Optics completed the acquisition of Fritz Ruck and MID Labs. This acquisition will help Hoya in leveraging MID Lab’s vitrectomy cutters, machines, and other vitreoretinal surgical products, thus, contributing towards the expansion of its product portfolio.
  • In May 2019, Alcon launched advancements to the CENTURION® Vision System at American Society for cataract and refractive surgery meeting.
Vitreoretinal Surgery Devices Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Vitreoretinal Surgery Devices Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Vitreoretinal Surgery Devices Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Vitreoretinal Surgery Devices Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the Vitreoretinal Surgery Devices Market?

Ans. The global Vitreoretinal Surgery Devices Market size was USD 1.7 Billion in 2021 and is anticipated to reach USD 2.5 Billion in 2031, growing at a rate of 3.9% from 2022 to 2031.

Q2. What is the Vitreoretinal Surgery Devices Market growth rate?

Ans. The growth rate of the Vitreoretinal Surgery Devices Market is 3.9%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Vitreoretinal Surgery Devices Market in 2021.

Q4. Which segment accounted for the largest Vitreoretinal Surgery Devices Market share?

Ans. By end-use, hospital segment accounted for the largest Vitreoretinal Surgery Devices Market share.

Q5. Who are the key players in the Clear Aligners Market?

Ans. The global Vitreoretinal Surgery Devices Market report includes players such  Alcon, Inc.Bausch & Lomb, Inc.OCULUS Optikgeräte GmbHMedOne Surgical, Inc.Carl Zeiss Meditec AGDesigns for Vision, Inc.Peregrine SurgicalD.O.R.C.Safilo Group, and Rodenstock., among others.

Q6. What are the factors driving the Vitreoretinal Surgery Devices Market growth?

Ans. The major factors driving the growth of the market are significant advancements related to vitreoretinal surgery devices

Q7. What are the key growth strategies of Vitreoretinal Surgery Devices Market players?

Ans. The key growth strategies of Vitreoretinal Surgery Devices Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period.

Read More
Single User License

Aquaculture Healthcare Market
November, 2022

The global Aquaculture Healthcare Market was valued at USD 1.3 billion in 2021 and it is anticipated to grow up to USD 1.6 billion by 2031, at a CAGR of 1.8% during the forecast period.

Aquaculture healthcare is the medical care and treatment of fish and other aquatic animals in aquaculture settings. This includes both preventive measures to maintain the health of the animals and treatment of sick or injured animals. Aquaculture healthcare is a vital part of ensuring the welfare of the animals and the quality of the products produced. Aquaculture healthcare is a growing field as the aquaculture industry continues to expand. Aquaculture facilities are found in many parts of the world and are an important source of food and income for many people. With the right care, these facilities can provide a safe and healthy environment for the animals and the people who work with them.

Global Aquaculture Healthcare Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$1.3 bn
Market Size in 2031$1.6 bn
Growth Rate (2021-31)11.6%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredBenchmark Holdings Plc., Alltech, Elanco, Bayer CropScience Limited, Merck & Co. Inc., Virbac S.A., ADM, Pfizer, Inc., AKVA Group, and Apex Frozen Foods Ltd.
Key CompaniesProduct, Species, Infections, Route of Administration, Distribution Channel, Region
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Rising demand for fish proteins across the world will boost the aquaculture healthcare market growth

Fish is a good source of protein and micronutrients and is consumed all over the world. For instance, in 2018, according to Food and Agriculture Organization (FAO) of the United Nations, about 88 percent of the 179 million tonnes of total fish production was utilized for direct human consumption. Thus, growing demand for quality fish has led to overfishing and depletion of wild fisheries. This is significantly increasing the demand for farmed fish produce. A growing aquaculture market is noted to increase the demand for aquaculture healthcare products in tandem.

Market Restraints and Challenges

Lack of knowledge regarding diseases in aquatic animals may slow the aquaculture healthcare market expansion

Limited awareness surrounding occurrence of diseases and benefits of aquaculture healthcare significantly impacts the industry revenue. This is estimated to be a concerning factor as it can render a sluggish rate of fish production coupled with an increasing rate of death, thereby limiting the market progression.

Global Aquaculture Healthcare Market Segmental Overview

The report analyses the global Aquaculture Healthcare Market based on Product, Species, Infections, Route of Administration, Distribution Channel, and Region

Global Aquaculture Healthcare Market by Product

Based on the product type, the Aquaculture Healthcare industry is bifurcated into drug, vaccine, and Medicated feed additives. Of these, the drug segment registered significant revenue in 2021. Consumers are increasingly relying on tablets, given their cost-effectiveness and high content of active ingredients, among other benefits, such as shelf-stability and ability to retain its potency for a longer period. Meanwhile, the ability of capsules to offer faster relief to symptoms, along with their higher bioavailability, will escalate the consumption of Aquaculture Healthcare in tablet and capsule forms.

Global Aquaculture Healthcare Market by Species

Based on species, market is segmented into Fishes, and Crustaceans. The fishes segment dominated more than 82.4% of the market share in 2021. Owing to the increasing demand for superior fish protein and the considerable expansion of the aquaculture market, there is a massive need for aquaculture healthcare solutions, thereby fuelling the industry progression. Additionally, rising fish farming is one of the major factors contributing to the market value.

.Global Aquaculture Healthcare Market by Infection

Based on applications, the Aquaculture Healthcare industry is categorized Bacterial infections, Viral infections, Parasitic infections, and Fungal infections. The segment bacterial infection accounted for lucrative market share in 2021. Farmed fishes show an increased incidence of bacterial infections in the market. This increased incidence is the result of crowded conditions in fish farms. Furthermore, poor sanitation, poor water quality and nutritional value result in increased susceptibility to bacteria.

Global Aquaculture Healthcare Market by Route of Adminstration

Based on the route of administration, the industry is categorized into Oral, Injectable, and Topical. The injectable segment accounted for 52% of revenue share in 2021 impelled by the effectiveness of injectable therapeutics. Drug diffusion varies due to the irregularity of metabolic processes in fish credited to their poikilothermic nature and poorly vascularized tissues. Injectable products offer direct delivery of antigen into muscle or body cavity, allowing rapid stimulation of immune response.

Geographical Analysis of Global Aquaculture Healthcare Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Aquaculture Healthcare market captured significant market share in 2021 and is poised to grow substantially during the forthcoming years. Increasing research and development investment by major players such as Zoetis Inc. and Merck & Co. is fuelling the market expansion. Moreover, the availability of diverse range of aquaculture healthcare solutions in the country will further stimulate the industry value. Furthermore, rising demand of fish food in the region will accelerate the demand for farmed fishes, further driving the demand for aquaculture healthcare products.

Major Players in the Global Aquaculture Healthcare Market

The key players in the market Benchmark Holdings Plc.AlltechElancoBayer CropScience LimitedMerck & Co. Inc.Virbac S.A.ADMPfizer, Inc.AKVA Group, and Apex Frozen Foods Ltd. among others.

COVID-19 Impact

The COVID-19 pandemic has negatively impacted the operations of several sectors and industries operating within, virtually resulting in an economic decline. Several fishing and aquaculture related activities we noted to be suspended considering the measure for countering the spread of COVID-19 pandemic. Thus, lowered demand of aquaculture produce limited the demand for therapeutic solutions for aquatic animals thereby, hampering the market. Moreover, several manufacturers operating in the aquaculture healthcare industry have reported significantly reduced workforce, thus negatively impacting the operational capabilities, thereby slowing down the industry growth. Furthermore, logistical challenges attributed to local and national restrictions on the movement of goods and people was noted to increase cost as well as turnaround time.

Recent Developments
  • In October 2022, Hyderabad-based Indian Immunologicals (IIL), a subsidiary of National Dairy Development Board (NDDB), has forayed into the aquaculture health segment with the launch of its products to serve the growing need in farmed shrimp and fish in the country.
  • In April 2021, ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.
  • In August 2020, Merck acquired IdentiGEN. This extended the company’s Livestock and Aquaculture products lineup
  • In January 2020, Lerøy Seafood Group and DNV GL had signed a contract to develop the product certification for STP 86 Salmo Salar. The STP-86 consists of the higher content of omega-3 acids.
Aquaculture Healthcare Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global Aquaculture Healthcare Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future Aquaculture Healthcare Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Aquaculture Healthcare Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.
Frequently Asked Questions

Q1. How big is the Aquaculture Healthcare Market?

Ans. The global Aquaculture Healthcare Market size was USD 1.3 billion in 2021 and is anticipated to reach USD 1.6 billion in 2031, growing at a rate of 1.8% from 2022 to 2031.

Q2. What is the Aquaculture Healthcare Market growth rate?

Ans. The growth rate of the Aquaculture Healthcare Market is 1.8%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Aquaculture Healthcare Market in 2021.

Q4. Which segment accounted for the largest Aquaculture Healthcare Market share?

Ans. By distribution channel, the specialty store segment accounted for the largest Aquaculture Healthcare Market share.

Q5. Who are the key players in the Aquaculture Healthcare Market?

Ans. The global Aquaculture Healthcare Market report includes players such as  Benchmark Holdings Plc.AlltechElancoBayer CropScience LimitedMerck & Co. Inc.Virbac S.A.ADMPfizer, Inc.AKVA Group, and Apex Frozen Foods Ltd., among others.

Q6. What are the factors driving the Aquaculture Healthcare Market growth?

Ans. The major factors driving the growth of the market are Growing incidence of diseases and parasites in farmed fish.

Q7. What are the key growth strategies of Aquaculture Healthcare Market players?

Ans. The key growth strategies of Aquaculture Healthcare Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Aquaculture Healthcare Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Aquaculture Healthcare Market during the forecast period.

Read More
Single User License